P3Y10000002000000100000001000000010000000false--12-31Q220190001144519Bunge LTD4410000007210000001130000001130000000.500.960.501.000.010.01400000000400000000141111081141533722141111081141533722P5Y000001.218752.43751.218752.43751001000.010.01210000002100000068996836899683689968368996831288231312882313 0001144519 2019-01-01 2019-06-30 0001144519 2019-07-26 0001144519 2018-01-01 2018-06-30 0001144519 2019-04-01 2019-06-30 0001144519 2018-04-01 2018-06-30 0001144519 2019-06-30 0001144519 2018-12-31 0001144519 2018-06-30 0001144519 2017-12-31 0001144519 bg:RedeemableNoncontrollingInterestMember 2018-12-31 0001144519 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-06-30 0001144519 us-gaap:TreasuryStockMember 2019-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2018-12-31 0001144519 us-gaap:RetainedEarningsMember 2018-12-31 0001144519 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001144519 us-gaap:RetainedEarningsMember 2019-06-30 0001144519 bg:CommonStockOutstandingMember 2019-01-01 2019-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2019-01-01 2019-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2019-06-30 0001144519 bg:CommonStockOutstandingMember 2019-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001144519 bg:ConvertiblePreferenceSharesMember 2019-06-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2018-12-31 0001144519 bg:CommonStockOutstandingMember 2018-12-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001144519 us-gaap:TreasuryStockMember 2018-12-31 0001144519 us-gaap:NoncontrollingInterestMember 2019-06-30 0001144519 us-gaap:RetainedEarningsMember 2018-03-31 0001144519 bg:ConvertiblePreferenceSharesMember 2018-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001144519 us-gaap:NoncontrollingInterestMember 2018-03-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2018-03-31 0001144519 bg:CommonStockOutstandingMember 2018-03-31 0001144519 bg:CommonStockOutstandingMember 2018-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2018-04-01 2018-06-30 0001144519 us-gaap:TreasuryStockMember 2018-06-30 0001144519 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001144519 bg:ConvertiblePreferenceSharesMember 2018-04-01 2018-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2018-04-01 2018-06-30 0001144519 2018-03-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001144519 us-gaap:TreasuryStockMember 2018-03-31 0001144519 bg:ConvertiblePreferenceSharesMember 2018-03-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001144519 bg:CommonStockOutstandingMember 2018-04-01 2018-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2018-06-30 0001144519 us-gaap:RetainedEarningsMember 2018-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2018-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001144519 bg:CommonStockOutstandingMember 2019-03-31 0001144519 bg:RedeemableNoncontrollingInterestMember 2019-04-01 2019-06-30 0001144519 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001144519 us-gaap:RetainedEarningsMember 2019-03-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001144519 bg:CommonStockOutstandingMember 2019-04-01 2019-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2019-03-31 0001144519 us-gaap:TreasuryStockMember 2019-03-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001144519 us-gaap:NoncontrollingInterestMember 2019-03-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001144519 bg:RedeemableNoncontrollingInterestMember 2019-03-31 0001144519 2019-03-31 0001144519 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-06-30 0001144519 bg:CommonStockOutstandingMember 2017-12-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2018-01-01 2018-06-30 0001144519 us-gaap:RetainedEarningsMember 2017-12-31 0001144519 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2017-12-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001144519 bg:RedeemableNoncontrollingInterestMember 2017-12-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2017-12-31 0001144519 us-gaap:TreasuryStockMember 2017-12-31 0001144519 bg:CommonStockOutstandingMember 2018-01-01 2018-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2018-01-01 2018-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001144519 bg:AccountingStandardsUpdate201802Member 2019-01-01 2019-03-31 0001144519 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001144519 bg:GlobalCompetitivenessProgramMember 2019-01-01 2019-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:EdibleOilProductsMember 2018-01-01 2018-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:MillingProductsMember 2019-01-01 2019-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:AgribusinessMember 2018-01-01 2018-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:SugarAndBioenergyMember 2019-01-01 2019-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:FertilizerMember 2018-01-01 2018-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:MillingProductsMember 2018-01-01 2018-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:FertilizerMember 2019-01-01 2019-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:AgribusinessMember 2019-01-01 2019-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:EdibleOilProductsMember 2019-01-01 2019-06-30 0001144519 bg:GlobalCompetitivenessProgramMember bg:SugarAndBioenergyMember 2018-01-01 2018-06-30 0001144519 bg:GlobalCompetitivenessProgramMember 2018-01-01 2018-06-30 0001144519 us-gaap:SellingGeneralAndAdministrativeExpensesMember bg:GlobalCompetitivenessProgramMember 2019-01-01 2019-06-30 0001144519 bg:OtherIndustrialInitiativesMember 2018-01-01 2018-06-30 0001144519 us-gaap:CostOfSalesMember bg:GlobalCompetitivenessProgramMember 2019-01-01 2019-06-30 0001144519 us-gaap:CostOfSalesMember bg:GlobalCompetitivenessProgramMember 2018-01-01 2018-06-30 0001144519 bg:OtherIndustrialInitiativesMember 2019-01-01 2019-06-30 0001144519 us-gaap:SellingGeneralAndAdministrativeExpensesMember bg:GlobalCompetitivenessProgramMember 2018-01-01 2018-06-30 0001144519 us-gaap:EmployeeSeveranceMember bg:GlobalCompetitivenessProgramMember 2019-06-30 0001144519 us-gaap:EmployeeSeveranceMember bg:GlobalCompetitivenessProgramMember 2019-01-01 2019-06-30 0001144519 us-gaap:EmployeeSeveranceMember bg:GlobalCompetitivenessProgramMember 2018-12-31 0001144519 srt:MaximumMember us-gaap:LandMember 2019-06-30 0001144519 srt:MinimumMember 2018-12-31 0001144519 srt:MaximumMember 2019-01-01 2019-06-30 0001144519 srt:MaximumMember bg:OceanFreightVesselsAgreementMember 2019-06-30 0001144519 srt:MinimumMember bg:OceanFreightVesselsAgreementMember 2018-12-31 0001144519 bg:CertainFacilitiesMember 2019-01-01 2019-06-30 0001144519 srt:MaximumMember bg:OceanFreightVesselsAgreementMember 2018-12-31 0001144519 srt:MinimumMember 2019-01-01 2019-06-30 0001144519 bg:TimeDepositsAndLettersOfCreditsMember 2019-06-30 0001144519 bg:TimeDepositsAndLettersOfCreditsMember 2018-12-31 0001144519 bg:AgribusinessMember 2019-06-30 0001144519 bg:SugarAndBioenergyMember 2019-06-30 0001144519 bg:AgribusinessMember bg:MerchandisingActivitiesMember 2019-06-30 0001144519 bg:AgribusinessMember bg:MerchandisingActivitiesMember 2018-12-31 0001144519 bg:SugarAndBioenergyMember 2018-12-31 0001144519 bg:SugarAndBioenergyMember bg:MerchandisingActivitiesMember 2018-12-31 0001144519 bg:EdibleOilProductsMember 2019-06-30 0001144519 bg:SugarAndBioenergyMember bg:MerchandisingActivitiesMember 2019-06-30 0001144519 bg:EdibleOilProductsMember 2018-12-31 0001144519 bg:AgribusinessMember 2018-12-31 0001144519 bg:MillingProductsMember 2018-12-31 0001144519 bg:FertilizerMember 2019-06-30 0001144519 bg:FertilizerMember 2018-12-31 0001144519 bg:MillingProductsMember 2019-06-30 0001144519 us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0001144519 bg:OtherSecuritiesMember 2018-12-31 0001144519 us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001144519 us-gaap:BankTimeDepositsMember 2019-06-30 0001144519 us-gaap:EquitySecuritiesMember 2019-06-30 0001144519 bg:OtherSecuritiesMember 2019-06-30 0001144519 us-gaap:EquitySecuritiesMember 2018-12-31 0001144519 us-gaap:BankTimeDepositsMember 2018-12-31 0001144519 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001144519 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember 2019-04-01 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember 2018-04-01 2018-06-30 0001144519 bg:NotesAndLoansReceivableMember 2019-03-31 0001144519 bg:NotesAndLoansReceivableMember 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember 2018-06-30 0001144519 bg:NotesAndLoansReceivableMember 2018-03-31 0001144519 bg:NotesAndLoansReceivableMember 2018-01-01 2018-06-30 0001144519 bg:NotesAndLoansReceivableMember 2018-12-31 0001144519 bg:NotesAndLoansReceivableMember 2019-01-01 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember 2017-12-31 0001144519 bg:NotesAndLoansReceivableMember 2018-01-01 2018-12-31 0001144519 bg:NotesAndLoansReceivableMember bg:RenegotiatedAmountMember 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember bg:RenegotiatedAmountMember 2018-12-31 0001144519 bg:NotesAndLoansReceivableMember bg:OtherLongTermReceivablesMember 2018-12-31 0001144519 bg:NotesAndLoansReceivableMember bg:LegalCollectionProcessMember 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember bg:OtherLongTermReceivablesMember 2019-06-30 0001144519 bg:NotesAndLoansReceivableMember bg:LegalCollectionProcessMember 2018-12-31 0001144519 bg:AccountsReceivablePayableNetMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 bg:AccountsReceivablePayableNetMember 2019-04-01 2019-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2019-04-01 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2019-04-01 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2019-03-31 0001144519 bg:AccountsReceivablePayableNetMember 2019-06-30 0001144519 bg:AccountsReceivablePayableNetMember 2019-03-31 0001144519 us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2019-03-31 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2019-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2018-01-01 2018-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2019-01-01 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2018-04-01 2018-06-30 0001144519 us-gaap:OtherNoncurrentAssetsMember 2018-12-31 0001144519 us-gaap:OtherNoncurrentAssetsMember 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2018-01-01 2018-06-30 0001144519 us-gaap:OtherNoncurrentLiabilitiesMember 2019-06-30 0001144519 bg:AccountsReceivablePayableNetMember 2018-01-01 2018-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2018-04-01 2018-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2019-01-01 2019-06-30 0001144519 bg:AccountsReceivablePayableNetMember 2019-01-01 2019-06-30 0001144519 us-gaap:OtherNoncurrentLiabilitiesMember 2018-12-31 0001144519 bg:AccountsReceivablePayableNetMember 2018-04-01 2018-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2018-03-31 0001144519 us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2018-03-31 0001144519 bg:AccountsReceivablePayableNetMember 2018-03-31 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2018-06-30 0001144519 bg:AccountsReceivablePayableNetMember 2018-06-30 0001144519 bg:AccountsReceivablePayableNetMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2018-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2018-12-31 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2018-12-31 0001144519 bg:AccountsReceivablePayableNetMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 bg:AccountsReceivablePayableNetMember 2018-12-31 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:CreditDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 bg:CreditDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:CreditDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001144519 bg:CreditDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 bg:CreditDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 bg:CreditDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001144519 bg:CreditDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:CreditDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EnergyDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2019-06-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2018-12-31 0001144519 bg:AccountsReceivablePayableNetMember 2017-12-31 0001144519 bg:AccountsReceivablePayableNetMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2017-12-31 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2017-12-31 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 us-gaap:CashFlowHedgingMember 2018-04-01 2018-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001144519 us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2019-04-01 2019-06-30 0001144519 bg:OtherDerivativesMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001144519 bg:ForeignExchangeDebtMember us-gaap:NetInvestmentHedgingMember 2019-04-01 2019-06-30 0001144519 bg:OtherDerivativesMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2019-04-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2018-04-01 2018-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember 2018-04-01 2018-06-30 0001144519 us-gaap:CashFlowHedgingMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignCurrencyGainLossMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignCurrencyGainLossMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2018-04-01 2018-06-30 0001144519 us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001144519 us-gaap:CommodityContractMember 2019-04-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001144519 bg:ForeignExchangeDebtMember us-gaap:NetInvestmentHedgingMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2018-04-01 2018-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-04-01 2019-06-30 0001144519 us-gaap:CommodityContractMember 2018-04-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-01-01 2018-12-31 0001144519 us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:ShortMember 2019-06-30 0001144519 us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2018-01-01 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0001144519 us-gaap:CashFlowHedgingMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2018-01-01 2018-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember 2018-01-01 2018-06-30 0001144519 us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2019-01-01 2019-06-30 0001144519 bg:ForeignExchangeDebtMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-06-30 0001144519 bg:OtherDerivativesMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0001144519 us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignCurrencyGainLossMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 bg:ForeignExchangeDebtMember us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-06-30 0001144519 us-gaap:CommodityContractMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignCurrencyGainLossMember 2019-01-01 2019-06-30 0001144519 bg:OtherDerivativesMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FutureMember us-gaap:ShortMember 2018-12-31 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:SwapMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:FutureMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 bg:NaturalGasDerivativesMember us-gaap:SwapMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:OptionMember us-gaap:LongMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:OptionMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:OptionMember us-gaap:LongMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:SwapMember us-gaap:LongMember 2018-12-31 0001144519 bg:OtherDerivativesMember bg:SwapsandFuturesMember us-gaap:ShortMember 2019-06-30 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:SwapMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:FutureMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:OptionMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:FutureMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:SwapMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FutureMember us-gaap:ShortMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:ForeignExchangeForwardMember us-gaap:ShortMember 2019-06-30 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:ForwardContractsMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FutureMember us-gaap:LongMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:OptionMember us-gaap:ShortMember 2018-12-31 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:FutureMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:SwapMember us-gaap:ShortMember 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2019-06-30 0001144519 bg:NaturalGasDerivativesMember us-gaap:FutureMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:FutureMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:SwapMember us-gaap:LongMember 2019-06-30 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:ForwardContractsMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:SwapMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForwardContractsMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:SwapMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:SwapMember us-gaap:ShortMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:SwapMember us-gaap:LongMember 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:FutureMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:ForeignExchangeForwardMember us-gaap:ShortMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember us-gaap:LongMember 2018-12-31 0001144519 bg:NaturalGasDerivativesMember us-gaap:SwapMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:ForeignExchangeForwardMember us-gaap:LongMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:ForwardContractsMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 bg:OtherDerivativesMember bg:SwapsandFuturesMember us-gaap:LongMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2018-12-31 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:SwapMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 bg:NaturalGasDerivativesMember us-gaap:FutureMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:FutureMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:OptionMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:SwapMember us-gaap:LongMember 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForwardContractsMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:SwapMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:OptionMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:ForeignExchangeForwardMember us-gaap:LongMember 2019-06-30 0001144519 bg:OtherDerivativesMember bg:SwapsandFuturesMember us-gaap:ShortMember 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:SwapMember us-gaap:ShortMember 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:FutureMember us-gaap:ShortMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FutureMember us-gaap:ShortMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember us-gaap:LongMember 2019-06-30 0001144519 bg:NaturalGasDerivativesMember us-gaap:SwapMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:OptionMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 bg:NaturalGasDerivativesMember us-gaap:FutureMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:NaturalGasDerivativesMember us-gaap:FutureMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:ForwardContractsMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FutureMember us-gaap:LongMember 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:ForwardContractsMember us-gaap:LongMember 2019-01-01 2019-06-30 0001144519 us-gaap:InterestRateContractMember us-gaap:FutureMember us-gaap:LongMember 2018-12-31 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:OptionMember us-gaap:ShortMember 2019-06-30 0001144519 bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:FutureMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:OptionMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:OtherDerivativesMember bg:SwapsandFuturesMember us-gaap:LongMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:FutureMember us-gaap:LongMember 2019-06-30 0001144519 us-gaap:ForeignExchangeContractMember us-gaap:SwapMember us-gaap:ShortMember 2019-06-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:OptionMember us-gaap:ShortMember 2018-01-01 2018-12-31 0001144519 bg:NaturalGasDerivativesMember us-gaap:SwapMember us-gaap:LongMember 2018-01-01 2018-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:SwapMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:CommodityContractMember us-gaap:OptionMember us-gaap:ShortMember 2019-01-01 2019-06-30 0001144519 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0001144519 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001144519 bg:TermLoanTrancheAMember us-gaap:MediumTermNotesMember us-gaap:SubsequentEventMember 2019-07-01 0001144519 us-gaap:CommercialPaperMember 2019-06-30 0001144519 bg:TermLoanTrancheAMember us-gaap:MediumTermNotesMember us-gaap:SubsequentEventMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-07-01 0001144519 bg:BilateralCreditLinesMember 2019-06-30 0001144519 bg:TermLoanTrancheBMember us-gaap:MediumTermNotesMember us-gaap:SubsequentEventMember 2019-07-01 0001144519 bg:LiquidityFacilityMember 2019-06-30 0001144519 bg:LocalBankLineOfCreditMember 2019-06-30 0001144519 bg:TermLoanTrancheBMember us-gaap:MediumTermNotesMember us-gaap:SubsequentEventMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-07-01 0001144519 bg:TermLoanMember us-gaap:MediumTermNotesMember us-gaap:SubsequentEventMember 2019-07-01 2019-07-01 0001144519 bg:BungeSecuritizationBVMember 2019-01-01 2019-06-30 0001144519 bg:BungeSecuritizationBVMember 2018-01-01 2018-06-30 0001144519 bg:BungeSecuritizationBVMember 2018-12-31 0001144519 bg:BungeSecuritizationBVMember 2019-06-30 0001144519 bg:BungeSecuritizationBVMember 2019-02-19 0001144519 bg:BungeSCFGrainLLCMember us-gaap:EquityMethodInvesteeMember 2019-06-30 0001144519 bg:TollingPortServicesAdministrativeSupportandOtherServicesMember us-gaap:EquityMethodInvesteeMember 2019-01-01 2019-06-30 0001144519 bg:SoybeansandOtherCommodityProductsMember us-gaap:EquityMethodInvesteeMember 2019-01-01 2019-06-30 0001144519 us-gaap:EquityMethodInvesteeMember 2018-12-31 0001144519 bg:TollingPortServicesAdministrativeSupportandOtherServicesMember us-gaap:EquityMethodInvesteeMember 2018-01-01 2018-06-30 0001144519 us-gaap:EquityMethodInvesteeMember 2019-06-30 0001144519 bg:TollingPortServicesAdministrativeSupportandOtherServicesMember us-gaap:EquityMethodInvesteeMember 2019-04-01 2019-06-30 0001144519 bg:TollingPortServicesAdministrativeSupportandOtherServicesMember us-gaap:EquityMethodInvesteeMember 2018-04-01 2018-06-30 0001144519 bg:SoybeansandOtherCommodityProductsMember us-gaap:EquityMethodInvesteeMember 2018-04-01 2018-06-30 0001144519 bg:SoybeansandOtherCommodityProductsMember us-gaap:EquityMethodInvesteeMember 2019-04-01 2019-06-30 0001144519 bg:SoybeansandOtherCommodityProductsMember us-gaap:EquityMethodInvesteeMember 2018-01-01 2018-06-30 0001144519 bg:NavegacoesUnidasTapajosS.A.Member us-gaap:EquityMethodInvesteeMember 2019-06-30 0001144519 bg:OtherRelatedPartyMember 2019-06-30 0001144519 bg:LaborClaimsMember 2019-06-30 0001144519 bg:CivilAndOtherClaimsMember 2018-12-31 0001144519 bg:LaborClaimsMember 2018-12-31 0001144519 bg:CivilAndOtherClaimsMember 2019-06-30 0001144519 bg:NonIncomeTaxClaimsMember 2018-12-31 0001144519 bg:NonIncomeTaxClaimsMember 2019-06-30 0001144519 country:BR bg:PisCofinsLiabilityMember bg:TaxReturnExamination2004To2012Member 2018-01-01 2018-12-31 0001144519 country:BR bg:ICMSTaxLiabilityMember bg:TaxReturnExamination1990ToPresentMember 2018-01-01 2018-12-31 0001144519 country:BR bg:ICMSTaxLiabilityMember bg:TaxReturnExamination1990ToPresentMember 2019-01-01 2019-06-30 0001144519 country:BR bg:PisCofinsLiabilityMember bg:TaxReturnExamination2004To2012Member 2019-01-01 2019-06-30 0001144519 bg:UnconsolidatedAffiliatesFinancingGuaranteesMember 2019-06-30 0001144519 bg:ResidualValueGuaranteeMember 2019-06-30 0001144519 bg:UnconstitutionalICMSTaxCreditsMember 2019-06-30 0001144519 country:AR 2011-01-01 2011-12-31 0001144519 bg:WhollyOwnedSubsidiaryMember bg:BungeLimitedFinanceCorpBungeFinanceEuropeB.vAndBungeN.a.FinanceL.pMember us-gaap:GuaranteeOfIndebtednessOfOthersMember 2019-06-30 0001144519 country:BR bg:ValueAddedTaxClaimsICMSIPIAndCOFINSMember 2017-12-31 0001144519 bg:WhollyOwnedSubsidiaryMember bg:BungeLimitedFinanceCorpBungeFinanceEuropeB.vAndBungeN.a.FinanceL.pMember us-gaap:GuaranteeOfIndebtednessOfOthersMember 2019-01-01 2019-06-30 0001144519 us-gaap:PerformanceGuaranteeMember 2019-06-30 0001144519 country:AR 2019-06-30 0001144519 country:BR 2016-03-31 0001144519 us-gaap:GuaranteeOfIndebtednessOfOthersMember 2019-06-30 0001144519 bg:IOILodersCroklaanMember 2018-03-01 0001144519 bg:IOILodersCroklaanMember bg:IOILodersCroklaanMember 2018-03-01 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-04-01 2019-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-04-01 2019-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-04-01 2018-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-03-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2018-04-01 2018-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-03-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2018-03-31 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-04-01 2018-06-30 0001144519 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-06-30 0001144519 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-31 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-01-01 2018-06-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-06-30 0001144519 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2018-04-01 2018-06-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2018-01-01 2018-06-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2019-01-01 2019-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2018-04-01 2018-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2019-01-01 2019-06-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2019-04-01 2019-06-30 0001144519 bg:EdibleOilProductsMember 2019-04-01 2019-06-30 0001144519 bg:MillingProductsMember 2019-04-01 2019-06-30 0001144519 bg:FertilizerMember 2019-04-01 2019-06-30 0001144519 bg:AgribusinessMember 2019-04-01 2019-06-30 0001144519 bg:SugarAndBioenergyMember 2019-04-01 2019-06-30 0001144519 bg:EdibleOilProductsMember 2018-01-01 2018-06-30 0001144519 bg:MillingProductsMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:EdibleOilProductsMember 2018-06-30 0001144519 bg:AgribusinessMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:MillingProductsMember 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2018-01-01 2018-06-30 0001144519 bg:SugarAndBioenergyMember 2018-01-01 2018-06-30 0001144519 bg:FertilizerMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:AgribusinessMember 2018-01-01 2018-06-30 0001144519 bg:CorporateAndReconcilingItemsMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:AgribusinessMember 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2018-01-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:EdibleOilProductsMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:EdibleOilProductsMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:SugarAndBioenergyMember 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2018-01-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:FertilizerMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:MillingProductsMember 2018-01-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:FertilizerMember 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:FertilizerMember 2018-01-01 2018-06-30 0001144519 bg:CorporateAndReconcilingItemsMember 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:SugarAndBioenergyMember 2018-01-01 2018-06-30 0001144519 bg:EdibleOilProductsMember 2018-04-01 2018-06-30 0001144519 bg:SugarAndBioenergyMember 2018-04-01 2018-06-30 0001144519 bg:AgribusinessMember 2018-04-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:MillingProductsMember 2018-04-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:FertilizerMember 2018-04-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2018-04-01 2018-06-30 0001144519 bg:MillingProductsMember 2018-04-01 2018-06-30 0001144519 bg:CorporateAndReconcilingItemsMember 2018-04-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember 2018-04-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2018-04-01 2018-06-30 0001144519 bg:FertilizerMember 2018-04-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2018-04-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:SugarAndBioenergyMember 2018-04-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:EdibleOilProductsMember 2018-04-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:AgribusinessMember 2018-04-01 2018-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:FertilizerMember 2018-04-01 2018-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:EdibleOilProductsMember 2018-04-01 2018-06-30 0001144519 bg:AgribusinessMember 2019-01-01 2019-06-30 0001144519 bg:FertilizerMember 2019-01-01 2019-06-30 0001144519 bg:EdibleOilProductsMember 2019-01-01 2019-06-30 0001144519 bg:SugarAndBioenergyMember 2019-01-01 2019-06-30 0001144519 bg:MillingProductsMember 2019-01-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:EdibleOilProductsMember 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:SugarAndBioenergyMember 2019-06-30 0001144519 bg:CorporateAndReconcilingItemsMember 2019-04-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:EdibleOilProductsMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:EdibleOilProductsMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:FertilizerMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:MillingProductsMember 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:FertilizerMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:FertilizerMember 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2019-04-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:MillingProductsMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:AgribusinessMember 2019-06-30 0001144519 bg:CorporateAndReconcilingItemsMember 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:AgribusinessMember 2019-04-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:SugarAndBioenergyMember 2019-04-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2019-04-01 2019-06-30 0001144519 bg:CorporateAndReconcilingItemsMember 2019-01-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:SugarAndBioenergyMember 2019-01-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2019-01-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:AgribusinessMember 2019-01-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2019-01-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:EdibleOilProductsMember 2019-01-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2019-01-01 2019-06-30 0001144519 us-gaap:IntersegmentEliminationMember bg:FertilizerMember 2019-01-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:FertilizerMember 2019-01-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:EdibleOilProductsMember 2019-01-01 2019-06-30 0001144519 us-gaap:OperatingSegmentsMember bg:MillingProductsMember 2019-01-01 2019-06-30 0001144519 us-gaap:SubsequentEventMember 2019-07-22 2019-07-22 0001144519 srt:MinimumMember us-gaap:ScenarioForecastMember 2019-07-01 2019-09-30 0001144519 srt:MaximumMember us-gaap:ScenarioForecastMember 2019-07-01 2019-09-30 0001144519 us-gaap:UnsecuredDebtMember us-gaap:SubsequentEventMember 2019-07-22 2019-07-22 0001144519 bg:BPp.l.c.Member us-gaap:SubsequentEventMember 2019-07-22 2019-07-22 0001144519 us-gaap:SubsequentEventMember 2019-07-22 0001144519 us-gaap:ScenarioForecastMember 2019-07-01 2019-09-30 0001144519 bg:BPp.l.c.Member us-gaap:SubsequentEventMember 2019-07-22 xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:USD bg:employee utreg:t iso4217:BRL iso4217:JPY bg:subsidiary utreg:MMBTU bg:day bg:segment
Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from        to       
Commission File Number 001-16625
BUNGE LIMITED
(Exact name of registrant as specified in its charter)
Bermuda
 
98-0231912
(State or other jurisdiction of incorporation or
organization)
 
(I.R.S. Employer Identification No.)
 
 
 
50 Main Street
 
 
White Plains
 
 
New York
 
10606
(Address of principal executive offices)
 
(Zip Code)
(914) 684-2800
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý  No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  ý  No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
ý
Accelerated filer
Non-accelerated filer
(Do not check if a smaller
reporting company)
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934).  Yes    No  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).  Yes    No  ý
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Shares, $0.01 par value per share
 
BG
 
New York Stock Exchange
As of July 26, 2019 the number of shares issued of the registrant was:
Common shares, par value $.01 per share: 141,556,942



Table of Contents

BUNGE LIMITED
TABLE OF CONTENTS
 
 
Page
 
 
 
 
Item 1.
 
 
 
 
 
3
 
 
 
 
4
 
 
 
 
5
 
 
 
 
6
 
 
 
 
7
 
 
 
 
9
 
 
 
 
37
 
 
 
Item 2.
38
 
 
 
Item 3.
55
 
 
 
Item 4.
57
 
 
 
 
 
 
 
Item 1.
58
 
 
 
Item 1A.
58
 
 
 
Item 2.
58
 
 
 
Item 3.
58
 
 
 
Item 4.
58
 
 
 
Item 5.
58
 
 
 
Item 6.
58
 
 
 
59
 
 
59

2

Table of Contents

PART I— FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(U.S. dollars in millions, except per share data)
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
 
2019
 
2018
 
2019
 
2018
Net sales
 
$
10,096

 
$
12,147

 
$
20,034

 
$
22,788

Cost of goods sold
 
(9,584
)
 
(11,605
)
 
(19,085
)
 
(21,862
)
Gross profit
 
512

 
542

 
949

 
926

Selling, general and administrative expenses
 
(335
)
 
(377
)
 
(640
)
 
(721
)
Interest income
 
7

 
6

 
14

 
14

Interest expense
 
(88
)
 
(94
)
 
(163
)
 
(164
)
Foreign exchange gains (losses)
 
(11
)
 
(96
)
 
(18
)
 
(96
)
Other income (expense) – net
 
187

 
4

 
218

 
28

Income (loss) from continuing operations before income tax
 
272

 
(15
)
 
360

 
(13
)
Income tax (expense) benefit
 
(60
)
 
(2
)
 
(98
)
 
(21
)
Income (loss) from continuing operations
 
212

 
(17
)
 
262

 
(34
)
Income (loss) from discontinued operations, net of tax
 

 
7

 

 
5

Net income (loss)
 
212

 
(10
)
 
262

 
(29
)
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests
 
2


(2
)

(3
)

(4
)
Net income (loss) attributable to Bunge
 
214

 
(12
)
 
259

 
(33
)
Convertible preference share dividends
 
(9
)
 
(9
)
 
(17
)
 
(17
)
Net income (loss) available to Bunge common shareholders
 
$
205

 
$
(21
)
 
$
242

 
$
(50
)
 
 
 
 
 
 
 
 
 
Earnings per common share—basic (Note 19)
 
 

 
 

 
 

 
 

Net income (loss) from continuing operations
 
$
1.46

 
$
(0.20
)
 
$
1.72

 
$
(0.39
)
Net income (loss) from discontinued operations
 

 
0.05

 

 
0.03

Net income (loss) attributable to Bunge common shareholders
 
$
1.46

 
$
(0.15
)
 
$
1.72

 
$
(0.36
)
 
 
 
 
 
 
 
 
 
Earnings per common share—diluted (Note 19)
 
 

 
 

 
 

 
 

Net income (loss) from continuing operations
 
$
1.43

 
$
(0.20
)
 
$
1.71

 
$
(0.39
)
Net income (loss) from discontinued operations
 

 
0.05

 

 
0.03

Net income (loss) attributable to Bunge common shareholders
 
$
1.43

 
$
(0.15
)
 
$
1.71

 
$
(0.36
)
The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(U.S. dollars in millions)
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
 
2019
 
2018
 
2019
 
2018
Net income (loss)
 
$
212

 
$
(10
)
 
$
262

 
$
(29
)
Other comprehensive income (loss):
 
 

 
 

 
 

 
 

Foreign exchange translation adjustment
 
97

 
(1,024
)
 
68

 
(1,036
)
  Unrealized gains (losses) on designated hedges, net of tax (expense) benefit of ($1) and ($1) in 2019 and $2 and $2 in 2018
 
(8
)
 
161

 
(31
)
 
164

Reclassification of realized net (gains) losses to net income, net of tax expense (benefit) of $1 and $1 in 2019 and nil and nil in 2018
 
(1
)
 
3

 
(2
)
 
(1
)
Pension adjustment, net of tax (expense) benefit of nil and nil in 2019 and nil and nil in 2018
 

 
2

 

 
1

Total other comprehensive income (loss)
 
88

 
(858
)
 
35

 
(872
)
Total comprehensive income (loss)
 
300

 
(868
)
 
297

 
(901
)
Less: comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests
 
(5
)
 
8

 
(1
)
 
3

Total comprehensive income (loss) attributable to Bunge
 
$
295

 
$
(860
)
 
$
296

 
$
(898
)

The accompanying notes are an integral part of these condensed consolidated financial statements.


4

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(U.S. dollars in millions, except share data)
 
 
June 30,
2019
 
December 31,
2018
ASSETS
 
 

 
 

Current assets:
 
 

 
 

Cash and cash equivalents
 
$
238

 
$
389

Trade accounts receivable (less allowances of $113 and $113) (Note 14)
 
1,711

 
1,637

Inventories (Note 6)
 
5,875

 
5,871

Other current assets (Note 7)
 
3,283

 
3,171

Total current assets
 
11,107

 
11,068

Property, plant and equipment, net
 
5,238

 
5,201

Operating lease assets (Note 4)
 
1,027

 

Goodwill
 
729

 
727

Other intangible assets, net
 
643

 
697

Investments in affiliates
 
474

 
451

Deferred income taxes
 
456

 
458

Other non-current assets (Note 8)
 
750

 
823

Total assets
 
$
20,424

 
$
19,425

LIABILITIES AND EQUITY
 
 

 
 

Current liabilities:
 
 

 
 

Short-term debt
 
$
1,885

 
$
750

Current portion of long-term debt (Note 13)
 
424

 
419

Trade accounts payable (includes $721 and $441 carried at fair value)
 
3,053

 
3,501

Current operating lease obligations (Note 4)
 
231

 

Other current liabilities (Note 10)
 
1,864

 
2,502

Total current liabilities
 
7,457

 
7,172

Long-term debt (Note 13)
 
4,039

 
4,203

Deferred income taxes
 
349

 
356

Non-current operating lease obligations (Note 4)
 
750

 

Other non-current liabilities
 
879

 
892

Commitments and contingencies (Note 16)
 


 


Redeemable noncontrolling interest (Note 17)
 
425

 
424

Equity (Note 18):
 
 

 
 

Convertible perpetual preference shares, par value $.01; authorized – 21,000,000 shares, issued and outstanding: 2019 and 2018 - 6,899,683 shares (liquidation preference $100 per share)
 
690

 
690

Common shares, par value $.01; authorized – 400,000,000 shares; issued and outstanding: 2019 – 141,533,722 shares, 2018 – 141,111,081 shares
 
1

 
1

Additional paid-in capital
 
5,300

 
5,278

Retained earnings
 
8,179

 
8,059

Accumulated other comprehensive income (loss) (Note 18)
 
(6,919
)
 
(6,935
)
Treasury shares, at cost - 2019 and 2018 - 12,882,313 shares
 
(920
)
 
(920
)
Total Bunge shareholders’ equity
 
6,331

 
6,173

Noncontrolling interests
 
194

 
205

Total equity
 
6,525

 
6,378

Total liabilities, redeemable noncontrolling interest and equity
 
$
20,424

 
$
19,425

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(U.S. dollars in millions)
 
 
Six Months Ended June 30,
 
 
2019
 
2018
OPERATING ACTIVITIES
 
 

 
 

Net income (loss)
 
$
262

 
$
(29
)
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
 
 

 
 

Impairment charges
 
22

 
4

Foreign exchange loss on net debt
 
38

 
171

Bad debt expense
 
4

 
23

Depreciation, depletion and amortization
 
294

 
304

Share-based compensation expense
 
17

 
21

Deferred income tax (benefit)
 
3

 
(50
)
Other, net
 
(13
)
 
5

Changes in operating assets and liabilities, excluding the effects of acquisitions:
 
 

 
 

Trade accounts receivable
 
(106
)
 
(245
)
Inventories
 
5

 
(2,202
)
Secured advances to suppliers
 
(120
)
 
(308
)
Trade accounts payable and accrued liabilities
 
(503
)
 
(48
)
Advances on sales
 
(169
)
 
(80
)
Net unrealized gains and losses on derivative contracts
 
(214
)
 
262

Margin deposits
 
121

 
(217
)
Marketable securities
 
(272
)
 
(56
)
Beneficial interest in securitized trade receivables
 
(521
)
 
(1,074
)
Other, net
 
69

 
(30
)
Cash provided by (used for) operating activities
 
(1,083
)
 
(3,549
)
INVESTING ACTIVITIES
 
 

 
 

Payments made for capital expenditures
 
(265
)
 
(220
)
Acquisitions of businesses (net of cash acquired)
 

 
(968
)
Proceeds from investments
 
213

 
945

Payments for investments
 
(277
)
 
(1,082
)
Settlement of net investment hedges
 
(39
)
 
12

Proceeds from beneficial interest in securitized trade receivables
 
547

 
1,064

Payments for investments in affiliates
 
(6
)
 

Other, net
 
12

 
32

Cash provided by (used for) investing activities
 
185

 
(217
)
FINANCING ACTIVITIES
 
 

 
 

Net change in short-term debt with maturities of 90 days or less
 
1,198

 
1,903

Proceeds from short-term debt with maturities greater than 90 days
 
44

 
231

Repayments of short-term debt with maturities greater than 90 days
 
(104
)
 
(63
)
Proceeds from long-term debt
 
3,262

 
5,926

Repayments of long-term debt
 
(3,496
)
 
(4,430
)
Proceeds from the exercise of options for common shares
 
7

 
11

Dividends paid to common and preference shareholders
 
(158
)
 
(147
)
Other, net
 
(8
)
 
(13
)
Cash provided by (used for) financing activities
 
745

 
3,418

Effect of exchange rate changes on cash and cash equivalents and restricted cash
 
8

 
(32
)
Net increase (decrease) in cash and cash equivalents and restricted cash
 
(145
)
 
(380
)
Cash and cash equivalents and restricted cash - beginning of period
 
393

 
605

Cash and cash equivalents and restricted cash - end of period
 
$
248

 
$
225

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS
(Unaudited)
(U.S. dollars in millions, except share data)
 
 
 
Convertible
Preference Shares
 
Common Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable
Non-
Controlling
Interests
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Treasury
Shares
 
Non-
Controlling
Interests
 
Total
Equity
Balance, April 1, 2019
 
$
421

6,899,683

 
$
690

 
141,469,061

 
$
1

 
$
5,284

 
$
8,045

 
$
(7,000
)
 
$
(920
)
 
$
204

 
$
6,304

Net income (loss)
 
(1
)

 

 

 

 

 
214

 

 

 
(1
)
 
213

Other comprehensive income (loss)
 
5


 

 

 

 

 

 
81

 

 
2

 
83

Dividends on common shares, $0.50 per share
 


 

 

 

 

 
(71
)
 

 

 

 
(71
)
Dividends on preference shares, $1.21875 per share
 


 

 

 

 

 
(9
)
 

 

 

 
(9
)
Dividends to noncontrolling interests on subsidiary common stock
 


 

 

 

 

 

 

 

 
(11
)
 
(11
)
Share-based compensation expense
 


 

 

 

 
13

 

 

 

 

 
13

Issuance of common shares, including stock dividends
 


 

 
64,661

 

 
3

 

 

 

 

 
3

Balance, June 30, 2019
 
$
425

6,899,683

 
$
690

 
141,533,722

 
$
1

 
$
5,300

 
$
8,179

 
$
(6,919
)
 
$
(920
)
 
$
194

 
$
6,525

 
 
 
Convertible
Preference Shares
 
Common Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable
Non-
Controlling
Interests
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Treasury
Shares
 
Non-
Controlling
Interests
 
Total
Equity
Balance, April 1, 2018
 
$
470

6,899,700

 
$
690

 
140,904,028

 
$
1

 
$
5,233

 
$
8,008

 
$
(5,947
)
 
$
(920
)
 
$
212

 
$
7,277

Net income (loss)
 
1


 

 

 

 

 
(12
)
 

 

 
1

 
(11
)
Other comprehensive income (loss)
 
(25
)

 

 

 

 

 

 
(848
)
 

 
(10
)
 
(858
)
Dividends on common shares, $0.50 per share
 


 

 

 

 

 
(70
)
 

 

 

 
(70
)
Dividends on preference shares, $1.21875 per share
 


 

 

 

 

 
(9
)
 

 

 

 
(9
)
Dividends to noncontrolling interests on subsidiary common stock
 


 

 

 

 

 

 

 

 
(6
)
 
(6
)
Acquisition of noncontrolling interest
 
(5
)

 

 

 

 

 

 

 

 

 

Share-based compensation expense
 


 

 

 

 
14

 

 

 

 

 
14

Issuance of (conversion to) common shares
 

(17
)
 

 
161,911

 

 
6

 

 

 

 

 
6

Balance, June 30, 2018
 
$
441

6,899,683

 
$
690

 
141,065,939

 
$
1

 
$
5,253

 
$
7,917

 
$
(6,795
)
 
$
(920
)
 
$
197

 
$
6,343


7

Table of Contents

 
 
 
Convertible
Preference Shares
 
Common Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable
Non-
Controlling
Interests
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Treasury
Shares
 
Non-
Controlling
Interests
 
Total
Equity
Balance, January 1, 2019
 
$
424

6,899,683

 
$
690

 
141,111,081

 
$
1

 
$
5,278

 
$
8,059

 
$
(6,935
)
 
$
(920
)
 
$
205

 
$
6,378

Net income (loss)
 
4


 

 

 

 

 
259

 

 

 
(1
)
 
258

Other comprehensive income (loss)
 
(3
)

 

 

 

 

 

 
37

 

 
1

 
38

Dividends on common shares, $1.00 per share
 


 

 

 

 

 
(142
)
 

 

 

 
(142
)
Dividends on preference shares, $2.4375 per share
 


 

 

 

 

 
(17
)
 

 

 

 
(17
)
Dividends to noncontrolling interests on subsidiary common stock
 


 

 

 

 

 

 

 

 
(12
)
 
(12
)
Contribution from noncontrolling interest
 


 

 

 

 

 

 

 

 
1

 
1

Share-based compensation expense
 


 

 

 

 
17

 

 

 

 

 
17

Impact of adoption of new accounting standards (1)
 


 

 

 

 

 
21

 
(21
)
 

 

 

Issuance of common shares, including stock dividends
 


 

 
422,641

 

 
5

 
(1
)
 

 

 

 
4

Balance, June 30, 2019
 
$
425

6,899,683

 
$
690

 
141,533,722

 
$
1

 
$
5,300

 
$
8,179

 
$
(6,919
)
 
$
(920
)
 
$
194

 
$
6,525


 
 
 
Convertible
Preference Shares
 
Common Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable
Non-
Controlling
Interests
Shares
 
Amount
 
Shares
 
Amount
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Treasury
Shares
 
Non-
Controlling
Interests
 
Total
Equity
Balance, January 1, 2018
 
$

6,899,700

 
$
690

 
140,646,829

 
$
1

 
$
5,226

 
$
8,081

 
$
(5,930
)
 
$
(920
)
 
$
209

 
$
7,357

Net income (loss)
 
1


 

 

 

 

 
(33
)
 

 

 
3

 
(30
)
Other comprehensive income (loss)
 
(21
)

 

 

 

 

 

 
(865
)
 

 
(7
)
 
(872
)
Dividends on common shares, $0.96 per share
 


 

 

 

 

 
(135
)
 

 

 

 
(135
)
Dividends on preference shares, $2.4375 per share
 


 

 

 

 

 
(17
)
 

 

 

 
(17
)
Dividends to noncontrolling interests on subsidiary common stock
 


 

 

 

 

 

 

 

 
(6
)
 
(6
)
Deconsolidation of a subsidiary
 


 

 

 

 

 

 

 

 
(2
)
 
(2
)
Acquisition of noncontrolling interest
 
461


 

 

 

 

 

 

 

 

 

Share-based compensation expense
 


 

 

 

 
21

 

 

 

 

 
21

Impact of adoption of new accounting standards
 


 

 

 

 

 
21

 

 

 

 
21

Issuance of (conversion to) common shares
 

(17
)
 

 
419,110

 

 
6

 

 

 

 

 
6

Balance, June 30, 2018
 
$
441

6,899,683

 
$
690

 
141,065,939

 
$
1

 
$
5,253

 
$
7,917

 
$
(6,795
)
 
$
(920
)
 
$
197

 
$
6,343

(1) See Note 2 for further details.

The accompanying notes are an integral part of these condensed consolidated financial statements.


8

Table of Contents

BUNGE LIMITED AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.
BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Limited (“Bunge”), its subsidiaries and variable interest entities (“VIEs”) in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (“Exchange Act”).  Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (“SEC”) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 2018 has been derived from Bunge’s audited consolidated financial statements at that date.  Operating results for the six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019.  The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2018, forming part of Bunge’s 2018 Annual Report on Form 10-K filed with the SEC on February 22, 2019.

Cash, Cash Equivalents, and Restricted Cash
Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheet that sums to the total of the same such amounts shown in the condensed consolidated statement of cash flows.
(US$ in millions)
June 30, 2019
June 30, 2018
Cash and cash equivalents
$
238

$
221

Restricted cash included in other current assets
10

4

Total
$
248

$
225


Statement of Cash Flows
On January 1, 2018, the Company adopted Accounting Standards Update ("ASU") 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force). Subsequent to the Company's initial adoption of ASU 2016-15, additional interpretative guidance was released by the SEC in the third quarter of 2018 that clarified the method to be used for calculating the cash received from payments on the deferred purchase price of securitized receivables. This additional guidance indicated that an entity must evaluate daily transaction activity to calculate the value of cash received from payments on the deferred purchase price. The company has applied this guidance on a retrospective basis, effective with the Form 10-Q for the quarterly period ended September 30, 2018, which resulted in a reclassification of cash inflows from operating activities to cash inflows from investing activities. Therefore, the condensed consolidated statement of cash flows for the six months ended June 30, 2018 has been revised to reflect this change.

2.
ACCOUNTING PRONOUNCEMENTS
The below outlines updates on certain previously disclosed ASUs.
New Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which introduces a new accounting model, referred to as the current expected credit losses ("CECL") model, for estimating credit losses on certain financial instruments and expands the disclosure requirements for estimating such credit losses. Under the new model, an entity is required to estimate the credit losses expected over the life of an exposure (or pool of exposures). The guidance also amends the current impairment model for debt securities classified as available-for-sale

9


securities. The new guidance will be effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. Bunge is evaluating the impact of this standard on its consolidated financial statements.    
Recently Adopted Accounting Pronouncements
On January 1, 2019 the Company adopted ASU 2016-02, Leases (Topic 842). Under the new provisions, all leases, except short-term leases, are recognized on the balance sheet as right-of-use assets and lease liabilities for the obligation to make payments under such leases. Bunge has elected the amended transition approach provided by ASU 2018-11, Leases (Topic 842): Targeted Improvements, which allows entities to apply the guidance as of the date of initial application by recognizing a cumulative-effect adjustment to opening retained earnings, with no retrospective adjustments. The Company also elected the package of practical expedients that permits the Company to not reassess under the new standard prior conclusions about lease identification, lease classification, and initial direct costs, as well as the practical expedient to not separate lease components from non-lease components in accounting for all classes of underlying assets. Upon adoption, the Company recorded $1,006 million of operating lease assets and $962 million of operating lease liabilities. Included in Operating lease assets at January 1, 2019 was $44 million of prepaid lease balances that were reclassified from Other non-current assets.
On January 1, 2019 the Company adopted ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220) - Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This ASU allows a reclassification from accumulated other comprehensive income ("AOCI") to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act ("Tax Act"). Consequently, the ASU eliminates the stranded tax effects resulting from the Tax Act and will improve the usefulness of information reported to financial statement users. However, because this ASU only relates to the reclassification of the income tax effects of the Tax Act, the underlying guidance that requires that the effect of a change in tax laws or rates be included in income from continuing operations is not affected. The Company's stranded tax effects relate to unrecognized costs associated with certain pension plans for which the tax benefit was initially recorded to AOCI. Absent this ASU, the Company's policy is to release stranded tax effects upon the pension plans' termination. Upon the adoption of this ASU, the Company elected to reclassify the income tax effects of the Tax Act, resulting in a decrease to AOCI and an increase to retained earnings of $21 million.
    

3.     GLOBAL COMPETITIVENESS PROGRAM
In July 2017, Bunge announced a comprehensive global competitiveness program to improve its cost position and deliver increased value to shareholders (the “Global Competitiveness Program” or "GCP"). When fully implemented, the GCP is expected to reduce the Company’s overhead costs by approximately $250 million annually by the end of 2019. The Company identified key elements of its strategy to meet this goal, including adopting a zero-based budgeting process that will target excess costs in specific budget categories and improving efficiency and scalability by simplifying organizational structures, streamlining processes and consolidating back office functions globally. In conjunction with the GCP, the Company has implemented other cost reduction and strategic initiatives to enhance the efficiency and performance of the Company’s business.

The table below sets forth, by segment, the types of costs recorded for the GCP.
 
Six Months Ended June 30,
 
2019
 
2018
(US$ in millions)
Severance and Other Employee Benefit Costs
 
Consulting and Professional Services
 
Other Program Costs
 
Total Program Costs
 
Severance and Other Employee Benefit Costs
 
Consulting and Professional Services
 
Total Program Costs
Agribusiness Segment
$
7

 
$
2

 
$
3

 
$
12

 
$
11

 
$
12

 
$
23

Edible Oils Segment
2

 
1

 

 
3

 
2

 
3

 
5

Milling Segment
1

 

 

 
1

 

 
2

 
2

Sugar and Bioenergy Segment
(1
)
 

 
1

 

 
2

 
3

 
5

Fertilizer Segment

 

 

 

 
2

 
1

 
3

Total
$
9

 
$
3

 
$
4

 
$
16

 
$
17

 
$
21

 
$
38


In addition to the above charges, $1 million and $1 million of severance and other employee benefit costs were recorded related to other industrial productivity initiatives for the six months ended June 30, 2019 and 2018, respectively. For

10


the six months ended June 30, 2019 and 2018 costs recorded above, $1 million and $7 million, respectively, were recorded in Cost of goods sold and $16 million and $32 million, respectively, were recorded in Selling, general and administrative expenses.

Bunge's liability associated with the GCP and other associated initiatives is primarily comprised of accruals for severance and other employee benefit costs. The following table sets forth the activity affecting the liability for severance and other employee benefit costs related to the GCP and other associated initiatives, which is recorded in Other current liabilities on the condensed consolidated balance sheet.
(US$ in millions)

Severance and Other Employee Benefit Costs
Balance at January 1, 2019
 
$
3

Charges incurred
 
9

Cash payments
 
(5
)
Balance at June 30, 2019
 
$
7



In addition to the cash charges described above, the Company's restructuring initiatives may include the sale or disposal of long-lived assets and rationalization of certain investments. As Bunge continues to review its opportunities, certain gains and charges may be recorded in earnings, including those related to the disposal of assets or investments. For the six months ended June 30, 2019 and 2018, nil and $15 million, respectively, of such charges have been recognized.

4.     LEASES
Bunge routinely leases storage facilities, transportation equipment, land, and office facilities which are typically classified as operating leases. The accounting for some of Bunge's leases may require significant judgment when determining whether a contract is or contains a lease, the lease term, and the likelihood of renewal or termination options. Leases with an initial term of more than 12 months are recognized on the balance sheet as right-of-use assets (Operating lease assets) and lease liabilities for the obligation to make payments under such leases (Current operating lease obligations and Non-current operating lease obligations). As of the lease commencement date, the lease liability is initially measured as the present value of lease payments not yet paid. The lease asset is initially measured equal to the lease liability and adjusted for lease payments made at or before lease commencement (e.g., prepaid rent), lease incentives, and any initial direct costs. Over time, the lease liability is reduced for lease payments made and the lease asset is reduced through expense, classified as either Cost of goods sold or Selling, general and administrative expense depending upon the nature of the lease. Lease assets are subject to review for impairment in a manner consistent with Property, plant and equipment. Leases with an initial term of 12 months or less (“short-term leases”) are not recorded on the balance sheet, and lease expense for these short-term leases is recognized on a straight-line basis over the lease term.
The Company’s leases range in length of term, with an average remaining lease term of 6.2 years, but with certain land leases continuing for up to 94 years. Additionally, certain leases contain renewal options that can extend the lease term up to an additional 5 years. Renewal options are generally exercisable solely at the Company’s discretion. When a renewal option is reasonably certain to be exercised, such additional terms are considered when calculating the associated operating lease asset and liability. When determining the lease liability at commencement of the lease, the present value of lease payments is based on the Company’s incremental borrowing rate determined using a portfolio approach and the Company’s incremental cost of debt, adjusted to arrive to the rate in the applicable country and for the applicable term of the lease, as the rate implicit in the lease is generally not readily determinable. As of June 30, 2019, such weighted average discount rate was 6.8%.
Certain of the Company’s freight supply agreements for ocean freight vessels and rail cars, as well as land leases associated with agricultural partnership agreements for the production of sugarcane, may include rental payments that are variable in nature. Variable payments on time charter agreements for ocean freight vessels under freight supply agreements are dependent on then current market daily hire rates. Variable payments for certain rail cars can be based on volumes, and in some cases, benchmark interest rates. Payments under the Company's agricultural partnership agreements in Brazil are dependent on the quantity of sugarcane produced per hectare, the total recoverable sugar ("ATR") per ton of sugarcane produced, and the price for each kilogram of ATR as determined by Consecana, the state of São Paulo sugarcane, sugar and ethanol council. All such variable payments are not included in the calculation of the associated operating lease asset or liability subsequent to the inception date of the associated lease and are recorded as expense in the period in which the adjustment to the variable payment obligation is incurred. Certain of the Company’s lease agreements related to railcars and barges contain residual value

11


guarantees (see Note 16, Commitments and Contingencies). None of the Company’s lease agreements contain material restrictive covenants.
The components of lease expense were as follows:
(US$ in millions)
 
Three Months Ended
June 30, 2019
 
Six Months Ended
June 30, 2019
Operating lease cost
 
$
80

 
$
160

Short-term lease cost
 
149

 
301

Variable lease cost
 
5

 
8

Sublease income
 
(20
)
 
(50
)
Total lease cost
 
$
214

 
$
419



Supplemental cash flow information related to leases was as follows:
(US$ in millions)
 
Six Months Ended
June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
       Operating cash flows associated with operating leases
 
$
160

Supplemental non-cash information:
 
 
       Right-of-use assets obtained in exchange for lease obligations
 
$
150


    
Maturities of lease liabilities for operating leases as of June 30, 2019, are as follows:
(US$ in millions)
 
Remaining in 2019
 
$
151

2020
 
253

2021
 
211

2022
 
166

2023
 
128

Thereafter
 
306

Total lease payments (1)
 
1,215

Less imputed interest
 
234

Present value of lease liabilities
 
$
981


(1) Minimum lease payments have not been reduced by minimum sublease income receipts of $37 million due in future periods under non-cancelable subleases. Non-cancelable subleases primarily relate to agreements with third parties for the use of portions of certain facilities with remaining sublease terms of approximately 5 years, as well as an agreement with an unconsolidated joint venture in which Bunge subleases rail cars with remaining sublease terms of approximately three to four years. Additionally, Bunge may enter into re-let agreements to sell the right to use ocean freight vessels under time charter agreements when excess capacity is available.

As of June 30, 2019, the Company has additional operating leases for freight supply agreements on ocean freight vessels, that have not yet commenced, of $185 million. These operating leases will commence in 2019 and 2020, with lease terms of up to eight years.











12



Prior year lease disclosures
The following pertains to previously disclosed information from Note 21, Commitments and contingencies and Note 26, Lease commitments, contained in Bunge's 2018 Annual Report on Form 10-K, which incorporates information about leases now in scope of ASC 842, Leases, disclosed above.
Operating lease for storage facilities, transportation equipment and office facilities—Future minimum lease payments by year and in the aggregate under non-cancelable operating leases with initial term of one year or more at December 31, 2018 are as follows:
(US$ in millions)
 
2019
$
134

2020
107

2021
84

2022
58

2023
48

Thereafter
126

Total (1)
$
557


(1) Minimum lease payments have not been reduced by minimum sublease income receipts of $43 million due in future periods under non-cancelable subleases.
Freight Supply Agreements—In the ordinary course of business, Bunge enters into time charter agreements for the use of ocean freight vessels for the purpose of transporting agricultural commodities. In addition, Bunge sells the right to use these ocean freight vessels when excess freight capacity is available. These agreements generally range from two months to approximately seven years. Future minimum payment obligations due under these agreements as of December 31, 2018 are as follows:
(US$ in millions)
 
2019
$
172

2020 and 2021
176

2022 and 2023
121

2024 and thereafter
37

Total
$
506




5.    TRADE STRUCTURED FINANCE PROGRAM
Bunge engages in various trade structured finance activities to leverage the value of its global trade flows. For the six months ended June 30, 2019 and 2018, net returns from these activities were $9 million and $14 million, respectively, and were included as a reduction of Cost of goods sold in the accompanying condensed consolidated statements of income. These activities include programs under which Bunge generally obtains U.S. dollar-denominated letters of credit (“LCs”), each based on an underlying commodity trade flow, from financial institutions and time deposits denominated in either the local currency of the financial institutions' counterparties or in U.S. dollars, as well as foreign exchange forward contracts, and other programs in which trade related payables are set-off against receivables, all of which are subject to legally enforceable set-off agreements.
As of June 30, 2019 and December 31, 2018, time deposits and LCs of $3,923 million and $4,729 million, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting, had been met. At June 30, 2019 and December 31, 2018, time deposits, including those presented on a net basis, carried weighted-average interest rates of 3.69% and 3.76%, respectively. During the six months ended June 30, 2019 and 2018, total net proceeds from issuances of LCs were $2,030 million and $3,243 million, respectively. These cash inflows are offset by the

13


related cash outflows resulting from placement of the time deposits and repayment of the LCs. All cash flows related to the programs are included in operating activities in the condensed consolidated statements of cash flows.

6.
INVENTORIES
Inventories by segment are presented below. Readily marketable inventories (“RMI”) are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, corn, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms.  Bunge engages in trading and distribution, or merchandising activities, and part of RMI can be attributable to such activities and is not held for processing. All other inventories are carried at lower of cost or net realizable value.
(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Agribusiness (1)
 
$
4,508

 
$
4,551

Edible Oil Products (2)
 
737

 
742

Milling Products
 
199

 
220

Sugar and Bioenergy (3)
 
315

 
280

Fertilizer
 
116

 
78

Total
 
$
5,875

 
$
5,871

 
(1)
Includes RMI of $4,275 million and $4,365 million at June 30, 2019 and December 31, 2018, respectively.  Of these amounts, $3,327 million and $3,300 million can be attributable to merchandising activities at June 30, 2019 and December 31, 2018, respectively.
(2)
Includes RMI of $102 million and $88 million at June 30, 2019 and December 31, 2018, respectively.
(3)
Includes RMI of $46 million and $79 million at June 30, 2019 and December 31, 2018, respectively. Of these amounts, $42 million and $74 million can be attributable to merchandising activities at June 30, 2019 and December 31, 2018, respectively.

7.
OTHER CURRENT ASSETS
Other current assets consist of the following:
(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Unrealized gains on derivative contracts, at fair value
 
$
936

 
$
1,071

Prepaid commodity purchase contracts (1)
 
372

 
253

Secured advances to suppliers, net (2)
 
263

 
257

Recoverable taxes, net
 
450

 
500

Margin deposits
 
227

 
348

Marketable securities, at fair value, and other short-term investments
 
514

 
162

Deferred purchase price receivable, at fair value (3)
 
102

 
128

Income taxes receivable
 
37

 
102

Prepaid expenses
 
147

 
165

Other
 
235

 
185

Total
 
$
3,283

 
$
3,171

 
(1)
Prepaid commodity purchase contracts represent advance payments against contracts for future delivery of specified quantities of agricultural commodities.

14


(2)
Bunge provides cash advances to suppliers, primarily Brazilian farmers of soybeans and sugarcane, to finance a portion of the suppliers’ production costs.  Bunge does not bear any of the costs or operational risks associated with the related growing crops.  The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmer’s crop is harvested and sold.  The secured advances to farmers are reported net of allowances of nil at June 30, 2019 and $1 million at December 31, 2018.
Interest earned on secured advances to suppliers of $6 million and $8 million for the three months ended June 30, 2019 and 2018, respectively, and $13 million and $18 million for the six months ended June 30, 2019 and 2018, respectively, is included in net sales in the condensed consolidated statements of income.
(3)
Deferred purchase price receivable represents additional credit support for the investment conduits in Bunge’s trade receivables securitization program (see Note 14).
Marketable Securities and Other Short-Term Investments - Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded in the condensed consolidated balance sheets for marketable securities and other short-term investments.
(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Foreign government securities
 
$
145

 
$
55

Corporate debt securities
 
120

 
91

Certificates of deposit/time deposits
 
91

 
15

Equity securities
 
157

 

Other
 
1

 
1

Total
 
$
514

 
$
162


As of June 30, 2019 and December 31, 2018, $422 million and $144 million, respectively, of marketable securities and other short-term investments are recorded at fair value. All other investments are recorded at cost, and due to the short-term nature of these investments, their carrying value approximates fair value. For the six months ended June 30, 2019, unrealized gains of $159 million have been recorded for investments still held at June 30, 2019.

8.
OTHER NON-CURRENT ASSETS
Other non-current assets consist of the following:
(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Recoverable taxes, net (1)
 
$
82

 
$
112

Judicial deposits (1)
 
121

 
115

Other long-term receivables
 
6

 
8

Income taxes receivable (1)
 
227

 
221

Long-term investments
 
76

 
91

Affiliate loans receivable
 
30

 
29

Long-term receivables from farmers in Brazil, net (1)
 
77

 
93

Other
 
131

 
154

Total
 
$
750

 
$
823

 
(1)
These non-current assets arise primarily from Bunge’s Brazilian operations and their realization could take several years.
Recoverable taxes, net - Recoverable taxes are reported net of allowances of $29 million and $27 million at June 30, 2019 and December 31, 2018, respectively.

15


Judicial deposits - Judicial deposits are funds that Bunge has placed on deposit with the courts in Brazil. These funds are held in judicial escrow relating to certain legal proceedings pending legal resolution and bear interest at the SELIC rate, which is the benchmark rate of the Brazilian central bank.
Income taxes receivable - Income taxes receivable includes overpayments of current income taxes plus accrued interest. These income tax prepayments are expected to be primarily utilized for settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the SELIC rate.
Affiliate loans receivable - Affiliate loans receivable are primarily interest-bearing receivables from unconsolidated affiliates with a remaining maturity of greater than one year.
Long-term receivables from farmers in Brazil, net - Bunge provides financing to farmers in Brazil, primarily through secured advances against farmer commitments to deliver agricultural commodities (primarily soybeans) upon harvest of the then-current year’s crop and through credit sales of fertilizer to farmers. Certain of such long-term receivables from farmers are originally recorded in other current assets as prepaid commodity contracts or secured advances to suppliers (see Note 7) and reclassified to other non-current assets when collection issues with farmers arise and amounts become past due and resolution of matters is expected to take more than one year.
The average recorded investment in long-term receivables from farmers in Brazil for the six months ended June 30, 2019 and the year ended December 31, 2018 was $203 million and $215 million, respectively.  The table below summarizes Bunge’s recorded investment in long-term receivables from farmers in Brazil and the related allowance amounts.
 
 
June 30, 2019
 
December 31, 2018
(US$ in millions)
 
Recorded
Investment
 
Allowance
 
Recorded
Investment
 
Allowance
For which an allowance has been provided:
 
 

 
 

 
 

 
 

Legal collection process (1)
 
$
106

 
$
90

 
$
105

 
$
89

Renegotiated amounts (2)
 
13

 
13

 
17

 
17

For which no allowance has been provided:
 
 

 
 

 
 

 
 

Legal collection process (1)
 
56

 

 
51

 

Renegotiated amounts (2)
 
5

 

 
10

 

Other long-term receivables
 

 

 
16

 

Total
 
$
180

 
$
103

 
$
199

 
$
106


(1)
All amounts in legal process are considered past due upon initiation of legal action.
(2)
All renegotiated amounts are current on repayment terms.
The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil.
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
 
2019
 
2018
Beginning balance
 
$
105

 
$
116

 
$
106

 
$
113

Bad debt provisions
 

 

 
1

 
4

Recoveries
 
(4
)
 
(2
)
 
(5
)
 
(3
)
Write-offs
 

 
(1
)
 

 
(1
)
Foreign exchange translation
 
2

 
(15
)
 
1

 
(15
)
Ending balance
 
$
103

 
$
98

 
$
103

 
$
98



9.
INCOME TAXES
Income tax expense is provided on an interim basis based on management’s estimate of the annual effective income tax rate and includes the tax effects of certain discrete items, such as changes in tax laws or tax rates or other unusual or non-

16


recurring tax adjustments in the interim period in which they occur. In addition, jurisdictions with a projected loss for the year or a year-to-date loss where no tax benefit can be recognized are excluded from the estimated annual effective tax rate. The effective tax rate is highly dependent on the geographic distribution of Bunge’s worldwide earnings or losses and tax regulations in each jurisdiction. Management regularly monitors the assumptions used in estimating its annual effective tax rate and adjusts estimates accordingly, including the realizability of deferred tax assets. Volatility in earnings within a taxing jurisdiction could result in a determination that additional valuation allowance adjustments may be warranted.
For the six months ended June 30, 2019 and 2018, income tax expense related to continuing operations was $98 million and $21 million, respectively. The effective tax rates for the six months ended June 30, 2019 and 2018 were impacted by an unfavorable earnings mix associated with pretax losses in certain jurisdictions.
As a global enterprise, Bunge files income tax returns that are subject to periodic examination and challenge by federal, state and foreign tax authorities. In many jurisdictions, income tax examinations, including settlement negotiations or litigation, may take several years to finalize. Bunge is currently under examination or litigation in various locations throughout the world. While it is difficult to predict the outcome or timing of resolution of any particular matter, management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.

10.
OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Unrealized losses on derivative contracts, at fair value
 
$
838

 
$
1,192

Accrued liabilities
 
535

 
618

Advances on sales
 
237

 
405

Other
 
254

 
287

Total
 
$
1,864

 
$
2,502



11.
FAIR VALUE MEASUREMENTS
The fair value standard describes three levels within its hierarchy that may be used to measure fair value.
Level
Description
Financial Instrument (Assets / Liabilities)
Level 1
Quoted price (unadjusted) in active markets for identical assets or liabilities.
Exchange traded derivative contracts.

Marketable securities in active markets.
Level 2
Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Exchange traded derivative contracts (less liquid market).

Readily marketable inventories.

Over-the-counter (‘‘OTC’’) commodity purchase and sale contracts.

OTC derivatives whose value is determined using pricing models with inputs that are generally based on exchange traded prices, adjusted for location specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data.

Marketable securities in less active markets.
Level 3
Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities.
Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques.
 
Assets and liabilities for which the determination of fair value requires significant management judgment or estimation.

17


In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. Bunge’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.
Bunge’s policy regarding the timing of transfers between levels, including both transfers into and transfers out of Level 3, is to measure and record the transfers at the end of the reporting period.
For a further definition of fair value and the associated fair value levels, refer to Note 15, Financial Instruments and Fair Value Measurements, included in Bunge's 2018 Annual Report on Form 10-K.
The following table sets forth, by level, Bunge’s assets and liabilities that were accounted for at fair value on a recurring basis.
 
 
Fair Value Measurements at Reporting Date
 
 
June 30, 2019
 
December 31, 2018
(US$ in millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Readily marketable inventories (Note 6)
 
$

 
$
3,651

 
$
772

 
$
4,423

 
$

 
$
4,286

 
$
246

 
$
4,532

Trade accounts receivable (1)
 


1




1

 







Unrealized gain on derivative contracts (2):
 
 
 
1
 
 

 
 

 
 

 
 

 
 

 
 

Interest rate
 

 
48

 

 
48

 

 
6

 

 
6

Foreign exchange
 

 
377

 

 
377

 

 
473

 

 
473

Commodities
 
35

 
415

 
13

 
463

 
128

 
407

 
18

 
553

Freight
 
14

 

 
2

 
16

 
6

 

 
6

 
12

Energy
 
72

 

 

 
72

 
30

 

 

 
30

Credit
 

 
1

 

 
1

 







Deferred purchase price receivable (Note 14)
 

 
102

 

 
102

 

 
128

 

 
128

Other (3)
 
171

 
274

 

 
445

 
67

 
98

 

 
165

Total assets
 
$
292

 
$
4,869

 
$
787

 
$
5,948

 
$
231

 
$
5,398

 
$
270

 
$
5,899

Liabilities:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Trade accounts payable (1)
 
$

 
$
386

 
$
335

 
$
721

 
$

 
$
394

 
$
47

 
$
441

Unrealized loss on derivative contracts (4):
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Interest rate
 

 
21

 

 
21

 

 
42

 

 
42

Foreign exchange
 

 
272

 

 
272

 

 
499

 

 
499

Commodities
 
54

 
375

 
23

 
452

 
152

 
446

 
23

 
621

Freight
 
20

 

 
4

 
24

 
13

 

 
6

 
19

Energy
 
68

 

 
2

 
70

 
43

 

 
1

 
44

Credit
 


1




1

 







Equity
 
1






1

 







Total liabilities
 
$
143

 
$
1,055

 
$
364

 
$
1,562

 
$
208

 
$
1,381

 
$
77

 
$
1,666

 
(1)
These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option.
(2)
Unrealized gains on derivative contracts are generally included in other current assets. There were $41 million and $3 million included in other non-current assets at June 30, 2019 and December 31, 2018, respectively.
(3)
Other includes the fair values of marketable securities, cash and cash equivalents and investments in other current assets and other non-current assets.
(4)
Unrealized losses on derivative contracts are generally included in other current liabilities. There are $3 million and $33 million included in other non-current liabilities at June 30, 2019 and December 31, 2018, respectively.

18


Readily marketable inventories—RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for differences in local markets where Bunge's inventories are located. In such cases, the inventory is classified within Level 2. Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3.
If Bunge used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the consolidated balance sheets and consolidated statements of income could differ. Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the consolidated balance sheets and consolidated statements of income could differ.
Derivatives—The majority of exchange traded futures and options contracts and exchange cleared contracts are valued based on unadjusted quoted prices in active markets and are classified within Level 1. The majority of the Bunge’s exchange-traded agricultural commodity futures are cash-settled on a daily basis and, therefore, are not included in these tables. Bunge's forward commodity purchase and sale contracts are classified as derivatives along with other OTC derivative instruments relating primarily to freight, energy, foreign exchange and interest rates, and are classified within Level 2 or Level 3 as described below. Bunge estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets. These differences are generally valued using inputs from broker or dealer quotations, or market transactions in either the listed or OTC markets. In such cases, these derivative contracts are classified within Level 2.
OTC derivative contracts include swaps, options and structured transactions that are generally fair valued using quantitative models that require the use of multiple market inputs including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets which are not highly active, other observable inputs relevant to the asset or liability, and market inputs corroborated by correlation or other means. These valuation models include inputs such as interest rates, prices and indices to generate continuous yield or pricing curves and volatility factors. Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2. Certain OTC derivatives trade in less active markets with less availability of pricing information and certain structured transactions can require internally developed model inputs that might not be observable in or corroborated by the market.
Level 3 Measurements
The following relates to Level 3 measurements. An instrument may transfer into or out of Level 3 due to inputs becoming either observable or unobservable.
Level 3 Readily marketable inventories and other—The significant unobservable inputs resulting in Level 3 classification for RMI, physically settled forward purchase and sale contracts, and trade accounts payable, relate to certain management estimations regarding costs of transportation and other local market or location-related adjustments, primarily freight related adjustments in the interior of Brazil and the lack of market corroborated information in Canada. In both situations, Bunge uses proprietary information such as purchase and sale contracts and contracted prices to value freight, premiums and discounts in its contracts. Movements in the price of these unobservable inputs alone would not have a material effect on Bunge's financial statements as these contracts do not typically exceed one future crop cycle.
Level 3 Derivatives—Level 3 derivative instruments utilize both market observable and unobservable inputs within the fair value measurements. These inputs include commodity prices, price volatility, interest rates, volumes and locations.
The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2019 and 2018.  These instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace

19


participant.
 
 
Three Months Ended June 30, 2019
(US$ in millions)
 
Readily
Marketable
Inventories

Derivatives,
Net

Trade
Accounts
Payable
 
Total
Balance, April 1, 2019
 
$
633

 
$
(2
)
 
$
(397
)
 
$
234

Total gains and losses (realized/unrealized) included in cost of goods sold (1)
 
145

 
(9
)
 
7

 
143

Purchases
 
626

 

 
(71
)
 
555

Sales
 
(764
)
 

 

 
(764
)
Issuances
 

 
(1
)
 

 
(1
)
Settlements
 

 

 
113

 
113

Transfers into Level 3
 
189

 
(2
)
 
(2
)
 
185

Transfers out of Level 3
 
(57
)
 

 
15

 
(42
)
Balance, June 30, 2019
 
$
772

 
$
(14
)
 
$
(335
)
 
$
423

1)
Readily marketable inventories, derivatives, net and trade accounts payable, include gains/(losses) of $63 million, $(11) million and $0 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2019.
 
 
Three Months Ended June 30, 2018
(US$ in millions)
 
Readily
Marketable
Inventories
 
Derivatives,
Net
 
Trade
Accounts Payable
 
Total
Balance, April 1, 2018
 
$
860

 
$
5

 
$
(317
)
 
$
548

Total gains and losses (realized/unrealized) included in cost of goods sold (1)
 
46

 
14

 
3

 
63

Purchases
 
532

 
1

 
(3
)
 
530

Sales
 
(267
)
 

 

 
(267
)
Issuances
 

 

 

 

Settlements
 

 
(1
)
 
110

 
109

Transfers into Level 3
 
151

 
(2
)
 
(76
)
 
73

Transfers out of Level 3
 
(97
)
 
(1
)
 
18

 
(80
)
Balance, June 30, 2018
 
$
1,225

 
$
16

 
$
(265
)
 
$
976


1) Readily marketable inventories, derivatives, net and trade accounts payable, includes gains/(losses) of $(16) million, $13 million and $0 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2018.

20




Six Months Ended June 30, 2019
(US$ in millions)

Readily
Marketable
Inventories

Derivatives,
Net

Trade
Accounts
Payable

Total
Balance, January 1, 2019

$
246


$
(6
)

$
(47
)

$
193

Total gains and losses (realized/unrealized) included in cost of goods sold (1)

183


(7
)

12


188

Purchases

1,325




(432
)

893

Sales

(1,334
)





(1,334
)
Issuances



(1
)



(1
)
Settlements





145


145

Transfers into Level 3

465




(28
)

437

Transfers out of Level 3

(113
)



15


(98
)
Balance, June 30, 2019

$
772


$
(14
)

$
(335
)

$
423


1)
Readily marketable inventories, derivatives, net and trade accounts payable, include gains/(losses) of $99 million, $(6) million and $0 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2019.

 
 
Six Months Ended June 30, 2018
(US$ in millions)
 
Readily
Marketable
Inventories

Derivatives,
Net

Trade
Accounts
Payable
 
Total
Balance, January 1, 2018
 
$
365

 
$
2

 
$
(116
)
 
$
251

Total gains and losses (realized/unrealized) included in cost of goods sold (1)
 
109

 
11

 
13

 
133

Purchases
 
1,145

 
10

 
(251
)
 
904

Sales
 
(546
)
 

 

 
(546
)
Issuances
 

 
(9
)
 

 
(9
)
Settlements
 

 
7

 
150

 
157

Transfers into Level 3
 
275

 
(4
)
 
(79
)
 
192

Transfers out of Level 3
 
(123
)
 
(1
)
 
18

 
(106
)
Balance, June 30, 2018
 
$
1,225

 
$
16

 
$
(265
)
 
$
976

1)
Readily marketable inventories, derivatives, net and trade accounts payable, include gains/(losses) of $(19) million, $1 million and $0 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at June 30, 2018.

12.
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Bunge uses derivative instruments to manage several market risks, such as interest rate, foreign currency rate, and commodity risk. Some of those hedges Bunge enters into qualify for hedge accounting in the financial statements (Hedge Accounting Derivatives) and some, while intended as economic hedges, do not qualify or are not designated for hedge accounting (Economic Hedge Derivatives). As these derivatives impact the financial statements in different ways, they are discussed separately below.
Hedge Accounting Derivatives - Bunge uses derivatives in qualifying hedge accounting relationships to manage certain of its interest rate, foreign currency, and commodity risks. In executing these hedge strategies, Bunge primarily relies on the shortcut and critical terms match methods in designing its hedge accounting strategy, which results in little to no net earnings impact for these hedge relationships. Bunge monitors these relationships on a quarterly basis and will perform a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative.

21


Fair value hedges - These derivatives are used to hedge the effect of interest rate and currency exchange rate changes on certain long-term debt. Under fair value hedge accounting, the derivative is measured at fair value and the carrying value of hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. In other words, the earnings effect of an increase in the fair value of the derivative will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense. For cross currency swaps the changes in currency risk on the derivative are recognized in Foreign exchange gains (losses), and the changes in interest rate risk are recognized in Interest expense. Changes in basis risk are held in Accumulated other comprehensive income (loss) until realized through the coupon.
Cash flow hedges of currency risk - Bunge manages currency risk on certain forecasted purchases, sales, and selling, general and administrative expenses with currency forwards. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the currency forward is reclassified to Net sales, Cost of goods sold or Selling, general and administrative expenses. These hedges mature at various times through November 2020. Of the amount currently in Accumulated other comprehensive income (loss), $2 million is expected to be reclassified to earnings in the next twelve months.
Cash flow hedges of commodity risk - Bunge manages commodity price risk on certain forecasted purchases and sales with commodity futures. The change in the value of the future is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the commodity future is reclassified to Net sales or Cost of goods sold. These hedges mature at various times through October 2020. Of the amount currently in Accumulated other comprehensive income (loss), $3 million is expected to be reclassified to earnings in the next twelve months.
Net investment hedges - Bunge hedges the currency risk of certain of its foreign subsidiaries with currency forwards and intercompany loans for which the currency risk is remeasured through Accumulated other comprehensive income (loss). For currency forwards, the forward method is used. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings.
The table below provides information about the balance sheet values of hedged items and the notional amount of derivatives used in hedging strategies. The notional amount of the derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap). The notional amount is used to compute interest or other payment streams to be made under the contract and is a measure of Bunge’s level of activity. Bunge discloses derivative notional amounts on a gross basis.
(US$ in millions)
June 30, 2019
December 31, 2018
Unit of
Measure
Hedging instrument type:
 
 
 
Fair value hedges of interest rate risk
 
 
 
 
Carrying value of hedged debt
$
2,291

$
2,229

$ Notional
 
Cumulative adjustment to long-term debt from application of hedge accounting
$
38

$
(29
)
$ Notional
 
Interest rate swap - notional amount
$
2,260

$
2,266

$ Notional
 
 
 
 
 
Fair value hedges of currency risk
 
 
 
 
Carrying value of hedged debt
$
320

$
312

$ Notional
 
Cross currency swap - notional amount
$
321

$
313

$ Notional
 
 
 
 
 
Cash flow hedges of currency risk
 
 
 
 
Foreign currency forward - notional amount
$
164

$
50

$ Notional
 
 
 
 
 
Cash flow hedges of commodity risk
 
 
 
 
Commodity price risk future - notional amount
296


Metric Tons
 
 
 
 
 
Net investment hedges
 
 
 
 
Foreign currency forward - notional amount
$
1,141

$
1,888

$ Notional
 
Carrying value of non-derivative hedging instrument
$
907

$
912

$ Notional


22


Economic Hedge Derivatives - In addition to using derivatives in qualifying hedge relationships, Bunge enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations.
Interest rate derivatives are used to hedge exposures to the Company's financial instrument portfolios and debt issuances. The impact of changes in fair value of these instruments is primarily presented in Interest expense.
Currency derivatives are used to hedge the balance sheet and commercial exposures that arise from the Company's global operations. The impact of changes in fair value of these instruments is presented in Cost of goods sold when hedging commercial exposures and Foreign exchange gains (losses) when hedging monetary exposures.
Agricultural commodity derivatives are used primarily to manage the Company's inventory and forward purchase and sales contracts. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
Bunge uses derivative instruments referred to as forward freight agreements ("FFA") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
Bunge uses energy derivative instruments to manage its exposure to volatility in energy costs. Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The Company may also enter into other derivatives, including credit default swaps and equity derivatives to manage exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The table below summarizes the volume of economic derivatives as of June 30, 2019 and December 31, 2018. For those contracts traded bilaterally through the over-the-counter markets (e.g., forwards, forward rate agreements ("FRA") and swaps), the gross position is provided. For exchange traded (e.g., futures, FFAs and options) and cleared positions (e.g., energy swaps), the net position is provided.

23


 
June 30,
December 31,
 
 
2019
2018
Unit of
Measure
(US$ in millions)
Long
(Short)
Long
(Short)
Interest rate
 

 
 

 

 
   Swaps
$
7,547

$
(92
)
$
3,349

$
(111
)
$ Notional
   Futures
$
3

$

$

$

$ Notional
   FRAs
$
426

$
(485
)
$
139

$
(149
)
$ Notional
Currency
 
 
 
 
 
   Forwards
$
10,198

$
(11,144
)
$
13,713

$
(13,701
)
$ Notional
   Swaps
$
35

$
(69
)
$
127

$
(535
)
$ Notional
   Futures
$
62

$

$

$
(16
)
$ Notional
   Options
$
87

$
(79
)
$
869

$
(919
)
Delta
Agricultural commodities
 
 
 
 
 
   Forwards
28,726,008

(34,604,184
)
25,523,840

(29,314,930
)
Metric Tons
   Swaps

(5,624,547
)

(9,908,728
)
Metric Tons
   Futures
1,959,874


4,136,525


Metric Tons
   Options

(1,188,015
)
718,709


Metric Tons
Ocean freight
 
 
 
 
 
   FFA
1,970



(90
)
Hire Days
   FFA options
75


302


Hire Days
Natural gas
 
 
 
 
 
   Swaps
349,763


1,205,687


MMBtus
   Futures
1,605,372


2,268,190


MMBtus
Energy - other
 
 
 
 
 
   Forwards
5,534,290


5,536,290


Metric Tons
   Futures

(17,063
)

(29,367
)
Metric Tons
   Swaps
163,000


188,800


Metric Tons
Other
 
 
 
 
 
Swaps and futures
$
210

$
(1,824
)
$
52

$

$ Notional


24


The Effect of Derivative Instruments and Hedge Accounting on the Condensed Consolidated Statements of Income
The tables below summarize the net effect of derivative instruments and hedge accounting on the condensed consolidated statements of income for the three and six months ended June 30, 2019 and 2018.
 
 
Gain (Loss) Recognized in
Income on Derivative Instruments
 
 
Three Months Ended June 30,
(US$ in millions)
 
2019
2018
Income statement classification
Type of derivative
 
 
Net sales
 
 
 
Hedge accounting
Foreign currency
$
1

$
(1
)
 
 
 
 
Cost of goods sold
 
 
 
   Hedge accounting
Foreign currency
$

$
1

   Economic hedges
Foreign currency
91

(379
)
 
Commodities
(244
)
432

 
Other (1)

7

     Total Cost of goods sold
 
$
(153
)
$
61

 
 
 
 
Interest expense
 
 
 
   Hedge accounting
Interest rate
$
(5
)
$
(2
)
   Economic hedges
Interest rate
(7
)

     Total Interest expense
 
$
(12
)
$
(2
)
 
 
 
 
Foreign exchange gains (losses)
 
 
 
   Hedge accounting
Foreign currency
$
9

$
(15
)
   Economic hedges
Foreign currency
(7
)
(41
)
     Total Foreign exchange gains (losses)
 
$
2

$
(56
)
 
 
 
 
Other comprehensive income (loss)
 
 
 
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in other comprehensive income (loss) during the period
$
3

$
(7
)
Gains and losses on derivatives used as cash flow hedges of commodity price risk included in other comprehensive income (loss) during the period
$
8

$

Gains and losses on derivatives used as net investment hedges included in other comprehensive income (loss) during the period
$
(7
)
$
114

Foreign currency gains and losses on intercompany loans used as net investment hedges included in other comprehensive income (loss) during the period
$
(12
)
$
52

 
 
 
Amounts released from accumulated other comprehensive income (loss) during the period
 
 
   Cash flow hedge of foreign currency risk
$
1

$
(4
)
(1) Other includes the results from freight, energy and other derivatives.


25


 
 
Gain (Loss) Recognized in
Income on Derivative Instruments
 
 
Six Months Ended June 30,
(US$ in millions)
 
2019
2018
Income statement classification
Type of derivative
 
 
Net sales
 
 
 
Hedge accounting
Foreign currency
$
2

$
(1
)
 
 
 
 
Cost of goods sold
 
 
 
   Hedge accounting
Foreign currency
$

$
1

   Economic hedges
Foreign currency
166

(414
)
 
Commodities
(106
)
172

 
Other (1)
28


     Total Cost of goods sold
 
$
88

$
(241
)
 
 
 
 
Interest expense
 
 
 
   Hedge accounting
Interest rate
$
(8
)
$

   Economic hedges
Interest rate
(10
)

     Total Interest expense
 
$
(18
)
$

 
 
 
 
Foreign exchange gains (losses)
 
 
 
   Hedge accounting
Foreign currency
$
8

$
(12
)
   Economic hedges
Foreign currency
31

(44
)
     Total Foreign exchange gains (losses)
 
$
39

$
(56
)
 
 
 
 
Other comprehensive income (loss)
 
 
 
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in other comprehensive income (loss) during the period
$
(2
)
$
(1
)
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in other comprehensive income (loss) during the period
$
3

$
(5
)
Gains and losses on derivatives used as cash flow hedges of commodity price risk included in other comprehensive income (loss) during the period
$
8

$

Gains and losses on derivatives used as net investment hedges included in other comprehensive income (loss) during the period
$
(45
)
$
133

Foreign currency gains and losses on intercompany loans used as net investment hedges included in other comprehensive income (loss) during the period
$
5

$
35

 
 
 
Amounts released from accumulated other comprehensive income (loss) during the period
 
 
   Cash flow hedge of foreign currency risk
$
2

$
(1
)

(1) Other includes the results from freight, energy and other derivatives.

13.
DEBT
Bunge’s commercial paper program is supported by an identical amount of committed back-up bank credit lines (the “Liquidity Facility”) provided by banks that are rated at least A-1 by Standard & Poor’s Financial Services and P-1 by Moody’s Investors Service. The cost of borrowing under the Liquidity Facility would typically be higher than the cost of issuing under Bunge’s commercial paper program. At June 30, 2019, there were $544 million of borrowings outstanding under the commercial paper program and no borrowings under the Liquidity Facility.
In addition to committed facilities, from time to time, Bunge Limited and/or its financing subsidiaries enter into uncommitted bilateral short-term credit lines as necessary based on its financing requirements. At June 30, 2019, there was

26


$450 million outstanding under these bilateral short-term credit lines. Loans under such credit lines are non-callable by the respective lenders. In addition, Bunge's operating companies had $891 million in short-term borrowings outstanding under local bank lines of credit at June 30, 2019 to support working capital requirements.
At June 30, 2019, Bunge had $4,221 million of unused and available borrowing capacity under its committed credit facilities totaling $5,015 million with a number of lending institutions.
The fair value of Bunge’s long-term debt is based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge. The carrying amounts and fair value of long-term debt are as follows:
 
 
June 30, 2019
 
December 31, 2018
(US$ in millions)
 
Carrying
Value
 
Fair Value
(Level 2)
 
Carrying
Value
 
Fair Value
(Level 2)
Long-term debt, including current portion
 
$
4,463

 
$
4,522

 
$
4,622

 
$
4,584



On July 1, 2019, Bunge entered into an unsecured five-year multi-currency syndicated term loan agreement (the "Term Loan") in the Japanese loan market, with certain lenders party thereto. The Term Loan is comprised of two tranches: Tranche A, Japanese Yen 30.7 billion ($285 million) bearing interest at three-month LIBOR plus a margin of 0.75% and Tranche B, $90 million bearing interest at three-month LIBOR plus a margin of 1.30%. The proceeds were used to pre-pay amounts outstanding under Bunge’s existing multi-currency syndicated term loan facility in the Japanese loan market maturing in December 2019.

14.
TRADE RECEIVABLES SECURITIZATION PROGRAM
Bunge and certain of its subsidiaries participate in a trade receivables securitization program (the “Program”) with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers that provides for funding of receivables sold into the Program. On February 19, 2019, Bunge exercised a portion of the $300 million accordion feature under the Program to increase the aggregate size of the facility by $100 million from $700 million to an aggregate of $800 million.

(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Receivables sold which were derecognized from Bunge's balance sheet
 
$
807

 
$
826

Deferred purchase price included in other current assets
 
$
102

 
$
128


The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated with the Program. Servicing fees under the Program were not significant in any period.
 
 
Six Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
Gross receivables sold
 
$
4,663

 
$
4,830

Proceeds received in cash related to transfer of receivables
 
$
4,469

 
$
4,626

Cash collections from customers on receivables previously sold
 
$
3,846

 
$
4,711

Discounts related to gross receivables sold included in SG&A
 
$
8

 
$
6



Non-cash activity for the program in the reporting period is represented by the difference between gross receivables sold and cash collections from customers on receivables previously sold.

15.
RELATED PARTY TRANSACTIONS
Notes receivable - Bunge holds a note receivable from Navegações Unidas Tapajós S.A., a 50% equity method investment in Brazil, having a carrying value of $21 million at June 30, 2019, which matures in September 2021, with interest based on CDI, the average overnight interbank loan rate in Brazil.
Bunge holds a note receivable from Bunge SCF Grain LLC, a 50% equity method investment in the U.S., with a carrying value of $7 million at June 30, 2019, which matures on March 31, 2023, with an interest rate based on LIBOR.

27


In addition, Bunge held notes receivables from other related parties totaling $4 million at June 30, 2019.
Notes payable - Bunge holds a note payable with Bunge SCF Grain LLC with a carrying value of $14 million at June 30, 2019. This note matures on March 31, 2023 with a variable interest rate of 2.43%.
Other - Bunge purchased soybeans and other agricultural commodity products from certain of its unconsolidated investees and other related parties totaling $307 million and $352 million for the three months ended June 30, 2019 and 2018, respectively, and $661 million and $663 million for the six months ended June 30, 2019 and 2018, respectively. Bunge also sold soybeans and other agricultural commodity products to certain of its unconsolidated investees and other related parties totaling $96 million and $118 million for the three months ended June 30, 2019 and 2018, respectively, and $206 million and $219 million for the six months ended June 30, 2019 and 2018, respectively. In addition, Bunge receives services from and provides services to its unconsolidated investees, including tolling, port services, administrative support, and other services. During the three months ended June 30, 2019 and 2018, Bunge received services totaling $26 million and $31 million, respectively, and provided services of $6 million and $8 million, respectively. During the six months ended June 30, 2019 and 2018, Bunge received services totaling $50 million and $56 million, respectively, and provided services of $10 million and $11 million, respectively. Bunge believes all transaction values to be similar to those that would be conducted with third parties.
At June 30, 2019 and December 31, 2018, Bunge had approximately $42 million and $28 million of receivables from these related parties included in trade accounts receivable in the condensed consolidated balance sheets as of those dates. In addition, at June 30, 2019 and December 31, 2018, Bunge had approximately $55 million and $26 million of payables to these related parties included in trade accounts payable in the condensed consolidated balance sheets as of those dates.

16.    COMMITMENTS AND CONTINGENCIES
Bunge is party to claims and lawsuits, primarily non-income tax and labor claims in South America, arising in the normal course of business. Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation and other litigation, claims, government investigations and legal proceedings. The ability to predict the ultimate outcome of such matters involves judgments, estimates and inherent uncertainties. Bunge records liabilities related to legal matters when the exposure item becomes probable and can be reasonably estimated. Bunge management does not expect these matters to have a material adverse effect on Bunge’s financial condition, results of operations or liquidity. However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period the uncertainties are resolved should the liability substantially exceed the amount of provisions included in the condensed consolidated balance sheets. Included in other non-current liabilities at June 30, 2019 and December 31, 2018 are the following amounts related to these matters:
(US$ in millions)
 
June 30,
2019
 
December 31,
2018
Non-income tax claims
 
$
92

 
$
94

Labor claims
 
78

 
78

Civil and other claims
 
98

 
95

Total
 
$
268

 
$
267


Brazil Indirect Taxes
Non-income tax claims - These tax claims relate principally to claims against Bunge’s Brazilian subsidiaries, primarily value-added tax claims (ICMS, ISS, IPI and PIS/COFINS). The determination of the manner in which various Brazilian federal, state and municipal taxes apply to the operations of Bunge is subject to varying interpretations arising from the complex nature of Brazilian tax law. In addition to the matter discussed below, Bunge monitors other potential claims in Brazil regarding these value-added taxes. In particular, Bunge monitors the Brazilian federal and state governments’ responses to recent Brazilian Supreme Court decisions invalidating on constitutional grounds certain ICMS incentives and benefits granted by various states. While Bunge was not a recipient of any of the incentives and benefits that were the subject of these Supreme Court decisions, it has received other similar tax incentives and benefits which are being challenged before the Supreme Court. In August 2017, Complementary Law 160/2017 (“LC 160/2017”) was published, authorizing the states, through an agreement to be reached within the framework of CONFAZ (National Council of Fiscal Policy), to grant amnesty for tax debts arising from existing tax benefits granted without previous CONFAZ authorization and to maintain such existing benefits still in force for up to 15 years. In December 2017, Interstate Agreement ICMS 190/2017 was published to regulate Complementary Law 160/2017, which endorsed the past incentives granted by the Brazilian states of CONFAZ. Bunge has not received any tax assessment from the states that granted these incentives or benefits related to their validity and, based on Bunge's evaluation of this matter as required by U.S. GAAP, no liability has been recorded in the condensed consolidated financial statements.

28


On February 13, 2015, Brazil’s Supreme Federal Court ruled in a leading case that certain state ICMS tax credits for staple foods (including soy oil, margarine, mayonnaise and wheat flours) are unconstitutional. Bunge, like other companies in the Brazilian food industry, is involved in several administrative and judicial disputes with Brazilian states regarding these tax credits. While the leading case does not involve Bunge and each case is unique in facts and circumstances and applicable state law, the ruling has general precedent authority in lower court cases. Based on management’s review of the ruling (without considering the future success of any potential clarification or modulation of the ruling) and its general application to Bunge’s pending cases, management recorded a liability in the fourth quarter of 2014. Since 2015, Bunge settled a portion of its outstanding liabilities in amnesty programs in certain Brazilian states. In the fourth quarter of 2018, Bunge participated in an amnesty program in the Brazilian state of Rio Grande do Sul, which resulted in a discounted settlement of certain cases. As a result, the liability was reduced to 241 million Brazilian reais (approximately $63 million) as of June 30, 2019.
As of June 30, 2019, the Brazilian federal and state authorities have concluded examinations of the ICMS and PIS COFINS tax returns and have issued the outstanding claims (including applicable interest and penalties) as of:
(US$ in millions)
Years Examined
June 30, 2019
December 31, 2018
ICMS
1990 to Present
$
268

$
264

PIS/COFINS
2004 through 2015
$
234

$
231


Argentina Export Tax
Since 2010, the Argentine tax authorities have been conducting a review of income and other taxes paid by exporters and processors of cereals and other agricultural commodities in the country. In that regard, the Company has been subject to a number of assessments, proceedings, and claims related to its activities. During 2011, Bunge’s subsidiary in Argentina paid $112 million of accrued export tax obligations under protest and preserved its rights with respect to such payment. In 2012, the Argentine tax authorities further assessed interest on these payments, which as of June 30, 2019, totaled approximately $310 million. In 2012, the Argentine government suspended Bunge’s Argentine subsidiary from a registry of grain traders. While the suspension has not had a material adverse effect on Bunge’s business in Argentina, these actions have resulted in additional administrative requirements and increased logistical costs on domestic grain shipments within Argentina. Bunge is challenging these actions in the Argentine courts.
Labor claims — The labor claims are principally claims against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments and supplementary retirement benefits.
Civil and other claims — The civil and other claims relate to various disputes with third parties, including suppliers and customers.
During the first quarter of 2016, Bunge received a notice from the Brazilian Administrative Council for Economic Defense ("CADE") initiating an administrative proceeding against its Brazilian subsidiary and two of its employees, certain of its former employees, several other companies in the Brazilian wheat milling industry, and others for alleged anticompetitive activities in the north and northeast of Brazil. Additionally, in the second quarter of 2018, Bunge received a notification from CADE that it has extended the scope of an existing administrative proceeding relating to alleged anticompetitive practices in the Rio Grande port in Brazil to include certain of Bunge's Brazilian subsidiaries and certain former employees of those subsidiaries. Bunge is defending against these actions; however, the proceedings are at an early stage and Bunge cannot, at this time, reasonably predict the ultimate outcome of the proceedings or sanctions, if any, which may be imposed.
Guarantees — Bunge has issued or was a party to the following guarantees at June 30, 2019:
(US$ in millions)
 
Maximum
Potential
Future
Payments
Unconsolidated affiliates guarantee (1) (2)
 
$
310

Residual value guarantee (3)
 
260

Total
 
$
570

 
(1)
Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings which have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. In addition, a Bunge subsidiary has guaranteed the obligations of two of its affiliates and in connection therewith has secured its guarantee obligations through a pledge of one of its affiliate's shares plus loans receivable

29


from the affiliate to the financial institutions in the event that the guaranteed obligations are enforced. Based on the amounts drawn under such debt facilities at June 30, 2019, Bunge's potential liability was $159 million, and it has recorded a $18 million obligation related to these guarantees.
(2)
Bunge has issued guarantees to certain third parties related to performance of its unconsolidated affiliates. The terms of the guarantees are equal to the completion date of a port terminal which is expected to be completed in 2020. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. At June 30, 2019, Bunge's maximum potential future payments under these guarantees was $59 million, and no obligation has been recorded related to these guarantees.
(3)
Bunge has issued guarantees to certain financial institutions which are party to certain operating lease arrangements for railcars and barges. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2019 through 2024. At June 30, 2019, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations (see Note 4, Leases).
Bunge Limited has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. (“BNA”), an indirect wholly‑owned subsidiary, which guarantees all amounts due and owing by BNA to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.
In addition, Bunge Limited has provided full and unconditional parent level guarantees of the outstanding indebtedness under certain credit facilities entered into, and senior notes issued, by its 100% owned subsidiaries.  At June 30, 2019, Bunge’s condensed consolidated balance sheet includes debt with a carrying amount of $5,890 million related to these guarantees.  This debt includes the senior notes issued by two of Bunge’s 100% owned finance subsidiaries, Bunge Limited Finance Corp. and Bunge Finance Europe, B.V.  There are largely no restrictions on the ability of Bunge Limited Finance Corp. and Bunge Finance Europe B.V. or any other Bunge subsidiary to transfer funds to Bunge Limited.

17.    REDEEMABLE NONCONTROLLING INTEREST
In connection with the acquisition of a 70% ownership interest in IOI Loders Croklaan ("Loders"), the Company has entered into a put/call arrangement with the Loders minority shareholder and may be required or elect to purchase the additional 30% ownership interest in Loders within a specified time frame.
The Company classifies these redeemable equity securities outside of permanent stockholders’ equity as the equity securities are redeemable at the option of the holder. The carrying amount of redeemable noncontrolling interests is the greater of: (i) the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions or (ii) the redemption value. Any resulting increases in the redemption amount, in excess of the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss and distributions, are affected by corresponding charges against retained earnings. Additionally, any such charges to retained earnings will affect net income (loss) available to Bunge common shareholders as part of Bunge's calculation of earnings per common share.

30



18.
EQUITY
Accumulated other comprehensive income (loss) attributable to Bunge — The following table summarizes the balances of related after-tax components of accumulated other comprehensive income (loss) attributable to Bunge:
(US$ in millions)
 
Foreign Exchange
Translation
Adjustment

Deferred
Gains (Losses)
on Hedging
Activities

Pension and Other
Postretirement
Liability
Adjustments

Accumulated
Other
Comprehensive
Income (Loss)
Balance, April 1, 2019
 
$
(6,657
)
 
$
(169
)
 
$
(174
)
 
$
(7,000
)
Other comprehensive income (loss) before reclassifications
 
90

 
(8
)
 

 
82

Amount reclassified from accumulated other comprehensive income (loss)
 

 
(1
)
 

 
(1
)
Balance, June 30, 2019
 
$
(6,567
)
 
$
(178
)
 
$
(174
)
 
$
(6,919
)
(US$ in millions)
 
Foreign Exchange
Translation
Adjustment

Deferred
Gains (Losses)
on Hedging
Activities

Pension and Other
Postretirement
Liability
Adjustments

Accumulated
Other
Comprehensive
Income (Loss)
Balance, April 1, 2018
 
$
(5,562
)
 
$
(244
)
 
$
(141
)
 
$
(5,947
)
Other comprehensive income (loss) before reclassifications
 
(1,028
)
 
161

 
2

 
(865
)
Amount reclassified from accumulated other comprehensive income (loss)
 
14

 
3

 

 
17

Balance, June 30, 2018
 
$
(6,576
)
 
$
(80
)
 
$
(139
)
 
$
(6,795
)
(US$ in millions)
 
Foreign Exchange
Translation
Adjustment

Deferred
Gains (Losses)
on Hedging
Activities

Pension and Other
Postretirement
Liability
Adjustments

Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2019
 
$
(6,637
)
 
$
(145
)
 
$
(153
)
 
$
(6,935
)
Other comprehensive income (loss) before reclassifications
 
70

 
(31
)
 

 
39

Amount reclassified from accumulated other comprehensive income (loss)
 

 
(2
)
 
(21
)
 
(23
)
Balance, June 30, 2019
 
$
(6,567
)
 
$
(178
)
 
$
(174
)
 
$
(6,919
)
(US$ in millions)
 
Foreign Exchange
Translation
Adjustment
 
Deferred
Gains (Losses)
on Hedging
Activities

Pension and Other
Postretirement
Liability
Adjustments
 
Unrealized
Gains (Losses)
on
Investments
 
Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2018
 
$
(5,547
)
 
$
(244
)
 
$
(140
)
 
$
1

 
$
(5,930
)
Other comprehensive income (loss) before reclassifications
 
(1,043
)
 
164

 
1

 

 
(878
)
Amount reclassified from accumulated other comprehensive income (loss)
 
14

 

 

 
(1
)
 
13

Balance, June 30, 2018
 
$
(6,576
)
 
$
(80
)
 
$
(139
)
 
$

 
$
(6,795
)


31


19.    EARNINGS PER COMMON SHARE
The following table sets forth the computation of basic and diluted earnings per common share.
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
(US$ in millions, except for share data)
 
2019
 
2018
 
2019
 
2018
Income (loss) from continuing operations
 
$
212

 
$
(17
)
 
$
262

 
$
(34
)
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests
 
2

 
(2
)
 
(3
)
 
(4
)
Income (loss) from continuing operations attributable to Bunge
 
214

 
(19
)
 
259

 
(38
)
Convertible preference share dividends
 
(9
)
 
(9
)
 
(17
)
 
(17
)
Income (loss) from discontinued operations, net of tax
 

 
7

 

 
5

Net income (loss) available to Bunge common shareholders - Basic
 
205

 
(21
)
 
242

 
(50
)
Add back convertible preference share dividends
 
9

 

 

 

Net income (loss) available to Bunge common shareholders - Diluted
 
$
214

 
$
(21
)
 
$
242

 
$
(50
)
 
 
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding:
 
 

 
 

 
 

Basic
 
141,497,071

 
140,959,421

 
141,351,844

 
140,848,779

Effect of dilutive shares:
 
 

 
 

 
 

 
 

—stock options and awards (1)
 
310,272

 

 
345,445

 

—convertible preference shares (2)
 
8,329,297

 

 

 

Diluted
 
150,136,640

 
140,959,421

 
141,697,289

 
140,848,779

 
 
 
 
 
 
 
 
 
Basic earnings per common share:
 
 
 
 
 
 
 
 
Net income (loss) from continuing operations
 
$
1.46

 
$
(0.20
)
 
$
1.72

 
$
(0.39
)
Net income (loss) from discontinued operations
 

 
0.05

 

 
0.03

Net income (loss) attributable to Bunge common shareholders—basic
 
$
1.46

 
$
(0.15
)
 
$
1.72

 
$
(0.36
)
 
 
 
 
 
 
 
 
 
Diluted earnings per common share:
 
 
 
 
 
 
 
 
Net income (loss) from continuing operations
 
$
1.43

 
$
(0.20
)
 
$
1.71

 
$
(0.39
)
Net income (loss) from discontinued operations
 

 
0.05

 

 
0.03

Net income (loss) attributable to Bunge common shareholders—diluted
 
$
1.43

 
$
(0.15
)
 
$
1.71

 
$
(0.36
)
 
(1)
The weighted-average common shares outstanding-diluted excludes approximately 6 million and 7 million stock options and contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for the three months ended June 30, 2019 and 2018, respectively.
The weighted-average common shares outstanding-diluted excludes approximately 5 million and 7 million stock options and contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for the six months ended June 30, 2019 and 2018, respectively.
(2)
Weighted-average common shares outstanding-diluted for the three months ended June 30, 2018 excludes approximately 8 million weighted-average common shares that are issuable upon conversion of the convertible preference shares that were not dilutive and not included in the weighted-average number of common shares, respectively.


32


Weighted-average common shares outstanding-diluted for the six months ended June 30, 2019 and 2018 excludes approximately 8 million and 8 million, respectively, weighted-average common shares that are issuable upon conversion of the convertible preference shares that were not dilutive and not included in the weighted-average number of common shares, respectively.

20.
SEGMENT INFORMATION
Bunge has five reportable segments - Agribusiness, Edible Oil Products, Milling Products, Sugar and Bioenergy, and Fertilizer, which are organized based upon similar economic characteristics and are similar in nature of products and services offered, the nature of production processes, and the type and class of customer and distribution methods. The Agribusiness segment is characterized by both inputs and outputs being agricultural commodities and thus high volume and low margin. The Edible Oil Products segment involves the processing, production and marketing of products derived from vegetable oils. The Milling Products segment involves the processing, production and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment involves sugarcane growing and milling in Brazil, as well as sugarcane-based ethanol production and corn-based ethanol investments and related activities. The Fertilizer segment includes its port operations in Brazil and Argentina and its blending and retail operations in Argentina.
The “Other” column in the following table contains the reconciliation between the totals for reportable segments and Bunge consolidated totals, which consists primarily of amounts attributable to corporate and other items not allocated to the reportable segments, discontinued operations, and inter-segment eliminations. Transfers between the segments are generally valued at market. The segment revenues generated from these transfers are shown in the following table as “Inter-segment revenues.”
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2019
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Other (1)
 
Total
Net sales to external customers
 
$
7,068

 
$
2,206

 
$
430

 
$
284

 
$
108

 
$

 
$
10,096

Inter–segment revenues
 
1,078

 
41

 

 
1

 
18

 
(1,138
)
 

Foreign exchange gains (losses)
 
(10
)
 
(3
)
 
1

 
1

 

 

 
(11
)
Noncontrolling interests (1)
 

 

 

 
1

 

 
1

 
2

Other income (expense) – net
 
35

 
(1
)
 
9

 
(2
)
 
(1
)
 
147

 
187

Segment EBIT (2)
 
182

 
25

 
17

 
(11
)
 
6

 
135

 
354

Depreciation, depletion and amortization
 
(65
)
 
(40
)
 
(13
)
 
(36
)
 
(1
)
 

 
(155
)
Total assets
 
$
12,429

 
$
3,907

 
$
1,480

 
$
1,890

 
$
361

 
$
357

 
$
20,424

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2018
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Other (1)
 
Total
Net sales to external customers
 
$
8,725

 
$
2,325

 
$
426

 
$
582

 
$
89

 
$

 
$
12,147

Inter–segment revenues
 
1,228

 
54

 

 


 

 
(1,282
)
 

Foreign exchange gains (losses)
 
(93
)
 
5

 
(2
)
 
(4
)
 
(2
)
 

 
(96
)
Noncontrolling interests (1)
 
1

 
(2
)
 

 
(1
)
 

 

 
(2
)
Other income (expense) – net
 
22

 
(1
)
 
(2
)
 
(15
)
 

 

 
4

Segment EBIT (2)
 
106

 
11

 
26

 
(63
)
 
(9
)
 

 
71

Discontinued operations (3)
 

 

 

 

 

 
7

 
7

Depreciation, depletion and amortization
 
(64
)
 
(41
)
 
(14
)
 
(41
)
 
(2
)
 

 
(162
)
Total assets
 
$
14,113

 
$
4,077

 
$
1,527

 
$
1,974

 
$
280

 
$
153

 
$
22,124


33


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2019
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Other (1)
 
Total
Net sales to external customers
 
$
13,987

 
$
4,445

 
$
856

 
$
569

 
$
177

 
$

 
$
20,034

Inter–segment revenues
 
2,246

 
73

 

 
1

 
20

 
(2,340
)
 

Foreign exchange gains (losses)
 
(18
)
 
(1
)
 
3

 
(2
)
 

 

 
(18
)
Noncontrolling interests (1)
 
2

 
(6
)
 

 

 

 
1

 
(3
)
Other income (expense) – net
 
67

 

 
8

 
(2
)
 
(2
)
 
147

 
218

Segment EBIT (2)
 
291

 
73

 
34

 
(35
)
 
7

 
135

 
505

Discontinued operations (3)
 

 

 

 

 

 

 

Depreciation, depletion and amortization
 
(128
)
 
(80
)
 
(27
)
 
(56
)
 
(3
)
 

 
(294
)
Total assets
 
$
12,429

 
$
3,907

 
$
1,480

 
$
1,890

 
$
361

 
$
357

 
$
20,424

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2018
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Other (1)
 
Total
Net sales to external customers
 
$
16,187

 
$
4,474

 
$
835

 
$
1,145

 
$
147

 
$

 
$
22,788

Inter–segment revenues
 
2,294

 
91

 

 
18

 

 
(2,403
)
 

Foreign exchange gains (losses)
 
(93
)
 
4

 

 
(3
)
 
(4
)
 

 
(96
)
Noncontrolling interests (1)
 
1

 
(5
)
 

 

 
(1
)
 
1

 
(4
)
Other income (expense) – net
 
46

 
(4
)
 
(2
)
 
(13
)
 
1

 

 
28

Segment EBIT (2)
 
148

 
39

 
43

 
(87
)
 
(11
)
 

 
132

Discontinued operations (3)
 

 

 

 

 

 
5

 
5

Depreciation, depletion and amortization
 
(131
)
 
(73
)
 
(29
)
 
(67
)
 
(4
)
 

 
(304
)
Total assets
 
$
14,113

 
$
4,077

 
$
1,527

 
$
1,974

 
$
280

 
$
153

 
$
22,124

(1)
Includes noncontrolling interests share of interest and tax to reconcile to consolidated noncontrolling interest.
(2) 
Total segment earnings before interest and taxes (“EBIT”) is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes total segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, total segment EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. However, total segment EBIT is a non-GAAP financial measure and is not intended to replace net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, total segment EBIT is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of total segment EBIT to net income (loss) in the table below.
(3)
Represents net income (loss) from discontinued operations.


34


A reconciliation of total Segment EBIT to net income (loss) attributable to Bunge follows:
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
 
2019
 
2018
Total Segment EBIT from continuing operations
 
$
354

 
$
71

 
$
505

 
$
132

Interest income
 
7

 
6

 
14

 
14

Interest expense
 
(88
)
 
(94
)
 
(163
)
 
(164
)
Income tax (expense) benefit
 
(60
)
 
(2
)
 
(98
)
 
(21
)
Income (loss) from discontinued operations, net of tax
 

 
7

 

 
5

Noncontrolling interests' share of interest and tax
 
1

 

 
1

 
1

Net income (loss) attributable to Bunge
 
$
214

 
$
(12
)
 
$
259

 
$
(33
)


The Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging (ASC 815) and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts with Customers (ASC 606). The following tables provide a disaggregation of net sales to external customers between sales from contracts with customers and sales from other arrangements:
 
 
Three Months Ended June 30, 2019
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Total
Sales from other arrangements
 
$
6,842

 
$
453

 
$
20

 
$
151

 
$

 
$
7,466

Sales from contracts with customers
 
226

 
1,753

 
410

 
133

 
108

 
2,630

Net sales to external customers
 
$
7,068

 
$
2,206

 
$
430

 
$
284

 
$
108

 
$
10,096


 
 
Three Months Ended June 30, 2018
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Total
Sales from other arrangements
 
$
8,430

 
$
420

 
$
14

 
$
435

 
$

 
$
9,299

Sales from contracts with customers
 
295

 
1,905

 
412

 
147

 
89

 
2,848

Net sales to external customers
 
$
8,725

 
$
2,325

 
$
426

 
$
582

 
$
89

 
$
12,147


 
 
Six Months Ended June 30, 2019
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Total
Sales from other arrangements
 
$
13,559

 
$
912

 
$
35

 
$
356

 
$

 
$
14,862

Sales from contracts with customers
 
428

 
3,533

 
821

 
213

 
177

 
5,172

Net sales to external customers
 
$
13,987

 
$
4,445

 
$
856

 
$
569

 
$
177

 
$
20,034


 
 
Six Months Ended June 30, 2018
(US$ in millions)
 
Agribusiness
 
Edible
Oil
Products
 
Milling
Products
 
Sugar and
Bioenergy
 
Fertilizer
 
Total
Sales from other arrangements
 
$
15,568

 
$
843

 
$
25

 
$
887

 
$

 
$
17,323

Sales from contracts with customers
 
619

 
3,631

 
810

 
258

 
147

 
5,465

Net sales to external customers
 
$
16,187

 
$
4,474

 
$
835

 
$
1,145

 
$
147

 
$
22,788



35


21.
SUBSEQUENT EVENT
On July 22, 2019, certain indirect wholly owned subsidiaries of Bunge entered into a Business Combination Agreement (the “Business Combination Agreement”) with certain wholly owned subsidiaries of BP p.l.c. (collectively, “BP”) to form a 50/50 joint venture (the “Joint Venture”) relating to their sugar and bioenergy operations in Brazil.
Pursuant to the Business Combination Agreement, Bunge and BP will contribute their respective interests in their Brazilian sugar and bioenergy operations to the Joint Venture. Bunge will receive cash proceeds of $775 million in the transaction, comprising $700 million in respect of non-recourse Bunge debt to be assumed by the Joint Venture at closing, and $75 million from BP, subject to customary closing adjustments. Bunge intends to use the proceeds to reduce outstanding indebtedness under its credit facilities. The Joint Venture agreements will provide for certain exit rights of the parties, including private sale rights beginning 18 months after closing and the ability by Bunge to trigger an initial public offering of the Joint Venture after two years from closing, enabling future monetization potential. The transaction is expected to close in the fourth quarter of 2019, subject to customary closing conditions, including receipt of required regulatory approvals.
In connection with the entry into the Business Contribution Agreement, the Company will classify the assets and liabilities to be transferred to the Joint Venture under the Business Contribution Agreement as held for sale in its condensed, consolidated financial statements in the quarter ending September 30, 2019. Accordingly, the Company will record those assets and liabilities at fair value, less estimated transaction costs, through the closing date of the transaction. As a result of the classification as held for sale, the Company will recognize an impairment charge, principally related to the recognition of cumulative currency translation effects, estimated to be in the range of $1.5 billion to $1.7 billion, which charge will primarily be recorded in the quarter ending September 30, 2019. Other than estimated transaction costs of approximately $18 million to be included in the impairment charge, the Company does not expect to incur additional significant cash costs associated with the entry into the Joint Venture. The range of impairment charges described above represents the Company’s best estimate as of the date of this Quarterly Report on Form 10-Q. Actual amounts could differ based on operating results, changes in foreign exchange rates and other factors between the date hereof and the closing of the transaction.


36


Cautionary Statement Regarding Forward Looking Statements
This report contains both historical and forward looking statements.  All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act).  These forward looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities.  We have tried to identify these forward looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions.  These forward looking statements are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements.  The following important factors, among others, could cause actual results to differ from these forward-looking statements: industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products used in our business, fluctuations in energy and freight costs; competitive developments in our industries; the effects of weather conditions and the outbreak of crop and animal disease on our business; global and regional economic, agricultural, financial and commodities market, political, social and health conditions; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, dispositions, joint ventures and strategic alliances; our ability to achieve the efficiencies, savings and other benefits anticipated from our cost reduction, margin improvement, operational excellence and other business optimization initiatives; changes in government policies, laws and regulations affecting our business, including agricultural and trade policies and environmental, tax and biofuels regulation; our capital allocation plans, funding needs and financing sources; changes in foreign exchange policy or rates; the outcome of our strategic review process; the effectiveness of our risk management strategies; our ability to attract and retain executive management and key personnel; operational risks, including industrial accidents, natural disasters and cybersecurity incidents; and other factors affecting our business generally.
The forward looking statements included in this report are made only as of the date of this report, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.
You should refer to “Item 1A.  Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on February 22, 2019, and “Part II — Item 1A. Risk Factors” in this Quarterly Report on Form 10-Q for a more detailed discussion of these factors.

37



ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Second Quarter 2019 Overview

You should refer to “Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - Factors Affecting Operating Results" in our Annual Report on Form 10-K for the year ended December 31, 2018 for a discussion of key factors affecting operating results in each of our business segments. In addition, you should refer to “Item 9A, Controls and Procedures” in our Annual Report on Form 10-K for the year ended December 31, 2018 and to “Item 4, Controls and Procedures” in this Quarterly Report on Form 10-Q for the period ended June 30, 2019 for a discussion of our internal controls over financial reporting.

Non-U.S. GAAP Financial Measures

Total segment earnings before interest and taxes (“EBIT”) is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes total segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-U.S. GAAP financial measure and is not intended to replace net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT excludes EBIT attributable to noncontrolling interests and is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to net income (loss) attributable to Bunge below.

Three Months Ended June 30, 2019 Compared to Three Months Ended June 30, 2018

Net Income (Loss) Attributable to Bunge - For the quarter ended June 30, 2019, net income attributable to Bunge increased by $226 million to $214 million from a loss of $12 million for the quarter ended June 30, 2018. This increase resulted primarily from an increase in segment EBIT from our reportable segments of $148 million, predominantly in Agribusiness and Sugar and Bioenergy, as well as $135 million of EBIT associated with our corporate venture capital unit, partially offset by higher income tax expense.
Income Tax Expense - For the quarter ended June 30, 2019, income tax expense related to continuing operations was $60 million, compared to $2 million for the quarter ended June 30, 2018. The higher income tax expense for the second quarter of 2019 compared to the same period last year is primarily due to higher overall pretax income. The effective tax rate for the second quarter of 2019 was 22%. The effective tax rate for the second quarter of 2018 was significantly impacted by a pretax loss.
Segment Overview

Agribusiness - EBIT for the second quarter of 2019 was $182 million compared to $106 million in the second quarter of 2018. In Oilseeds, soy crush margins were lower due to the combination of farmer retention of soybeans in anticipation of higher prices and increased meal availability with the return of Argentine supply. However, second quarter results benefited from positive mark-to-market gains on forward soy crushing contracts as margins decreased in many markets toward the end of the quarter.
In Grains, improved origination results in South America, which benefited from lower costs and favorable freight results, more than offset lower results in North America, which was negatively impacted by the combination of extreme weather and low soybean export demand due to the U.S.-China trade dispute. Additionally, trading and distribution performance and results in our financial services businesses were higher than last year.
Edible Oil Products - EBIT for the second quarter of 2019 was $25 million compared to $11 million in the second quarter of 2018. Improved results in the quarter were primarily driven by higher margins in South America due to a better supply and demand balance of oil, and in North America on improved demand, while results in Europe and Asia were comparable to last year.

38

Table of Contents

Milling Products - EBIT for the second quarter of 2019 was $17 million compared to $26 million in the second quarter of 2018. Lower results were primarily driven by Brazil, where results were impacted by lower volumes and margins as consumers remain price sensitive, particularly in the food service channel.
Sugar and Bioenergy - EBIT for the second quarter of 2019 was a loss of $11 million, compared to a loss of $63 million in the second quarter of 2018. Higher sugarcane milling results were primarily driven by lower costs and increased ethanol volumes and prices, which were partially offset by lower sugar volumes and margins. Additionally, 2018 results were impacted by losses in sugar trading and distribution in preparation for exiting the business and a higher bad debt expense.
Fertilizer - EBIT for the second quarter of 2019 was $6 million compared to a loss of $9 million in the second quarter of 2018. Better results were primarily due to higher volumes and improved prices in Argentina, as well as the impact of favorable foreign currency translation compared to the prior year.
Other - EBIT of $135 million in the second quarter of 2019 relates to the results of our corporate venture capital unit, which benefited from the initial public offering of one of its investments during the second quarter of 2019 and subsequent unrealized mark-to-market gains.
Segment Results
A summary of certain items in our condensed consolidated statements of income and volumes by reportable segment for the periods indicated is set forth below.
 
 
Three Months Ended
June 30,
(US$ in millions, except volumes)
 
2019
 
2018
Volumes (in thousands of metric tons):
 
 

 
 

Agribusiness
 
34,009

 
37,398

Edible Oil Products
 
2,328

 
2,261

Milling Products
 
1,113

 
1,177

Sugar and Bioenergy
 
828

 
1,570

Fertilizer
 
305

 
254

 
 
 
 
 
Net sales:
 
 

 
 

Agribusiness
 
$
7,068

 
$
8,725

Edible Oil Products
 
2,206

 
2,325

Milling Products
 
430

 
426

Sugar and Bioenergy
 
284

 
582

Fertilizer
 
108

 
89

Total
 
$
10,096

 
$
12,147

 
 
 
 
 
Cost of goods sold:
 
 

 
 

Agribusiness
 
$
(6,754
)
 
$
(8,371
)
Edible Oil Products
 
(2,064
)
 
(2,202
)
Milling Products
 
(389
)
 
(363
)
Sugar and Bioenergy
 
(280
)
 
(580
)
Fertilizer
 
(97
)
 
(89
)
Total
 
$
(9,584
)
 
$
(11,605
)
 
 
 
 
 
Gross profit:
 
 

 
 

Agribusiness
 
$
314

 
$
354

Edible Oil Products
 
142

 
123


39

Table of Contents

Milling Products
 
41

 
63

Sugar and Bioenergy
 
4

 
2

Fertilizer
 
11

 

Total
 
$
512

 
$
542

 
 
 
 
 
Selling, general and administrative expenses:
 
 

 
 

Agribusiness
 
$
(157
)
 
$
(178
)
Edible Oil Products
 
(113
)
 
(114
)
Milling Products
 
(34
)
 
(33
)
Sugar and Bioenergy
 
(15
)
 
(45
)
Fertilizer
 
(4
)
 
(7
)
Other
 
(12
)
 

Total
 
$
(335
)
 
$
(377
)
 
 
 
 
 
Foreign exchange gains (losses):
 
 

 
 

Agribusiness
 
$
(10
)
 
$
(93
)
Edible Oil Products
 
(3
)
 
5

Milling Products
 
1

 
(2
)
Sugar and Bioenergy
 
1

 
(4
)
Fertilizer
 

 
(2
)
Total
 
$
(11
)
 
$
(96
)
 
 
 
 
 
EBIT attributable to noncontrolling interests:
 
 

 
 

Agribusiness
 
$

 
$
1

Edible Oil Products
 

 
(2
)
Milling Products
 

 

Sugar and Bioenergy
 
1

 
(1
)
Fertilizer
 

 

Total
 
$
1

 
$
(2
)
 
 
 
 
 
Other income (expense) - net:
 
 

 
 

Agribusiness
 
$
35

 
$
22

Edible Oil Products
 
(1
)
 
(1
)
Milling Products
 
9

 
(2
)
Sugar and Bioenergy
 
(2
)
 
(15
)
Fertilizer
 
(1
)
 

Other
 
147

 

Total
 
$
187

 
$
4

 
 
 
 
 
Segment EBIT:
 
 

 
 

Agribusiness
 
$
182

 
$
106

Edible Oil Products
 
25

 
11

Milling Products
 
17

 
26

Sugar and Bioenergy
 
(11
)
 
(63
)
Fertilizer
 
6

 
(9
)
Other
 
135

 

Total
 
$
354

 
$
71


40

Table of Contents

A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
 
 
Three Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
Net income (loss) attributable to Bunge
 
$
214

 
$
(12
)
Interest income
 
(7
)
 
(6
)
Interest expense
 
88

 
94

Income tax expense (benefit)
 
60

 
2

(Income) loss from discontinued operations, net of tax
 

 
(7
)
Noncontrolling interest's share of interest and tax
 
(1
)
 

Total Segment EBIT
 
$
354

 
$
71


Agribusiness Segment - Agribusiness segment net sales decreased by 19% to $7.1 billion in the second quarter of 2019, compared to $8.7 billion in the second quarter of 2018. The decrease was primarily due to lower volumes in our grain origination and distribution businesses, associated with lower supply in North America due to severe weather conditions impacting logistics, and slow farmer selling in Brazil, partially offset by higher volumes in Argentina following the drought in 2018. Sales were also lower in our oilseed processing and trading and distribution businesses, primarily driven by overall lower prices due to increased global soybean meal availability and lower demand from China as a result of the African swine fever outbreak.

Cost of goods sold decreased by 19% in line with the decreases in net sales in our grain and oilseed businesses related to lower volumes and prices as discussed above.

Gross profit decreased by $40 million in the second quarter of 2019 to $314 million from $354 million in the second quarter of 2018. The decrease was primarily associated with lower soy crush results in Brazil, caused by higher Brazilian soybean prices related to ongoing global trade tensions and in Argentina and Europe, as margins were lower due to higher global availability and lower demand for soybean meal. Additionally results in our oilseed trading and distribution business contributed to the lower results. These decreases were partially offset by mark-to-market gains related to forward oilseed crushing contracts and improved results in our China soy crush business due to improved margins.

SG&A expenses decreased $21 million to $157 million in the second quarter of 2019, from $178 million in the same period last year. The decrease was mainly due to savings from our global competitiveness program ("GCP"), as well as lower charges recognized in the second quarter of 2019 associated with execution of the GCP as compared to the same period last year, and from the depreciation of the Brazilian real against the U.S. dollar.

Foreign exchange results in the second quarter of 2019 were losses of $10 million, compared to losses $93 million in the second quarter of 2018. Foreign exchange results are primarily driven by funding non-U.S. functional currency operations. Results in 2018 were primarily driven by the devaluation of the Argentine peso on U.S. dollar loans to fund operations in Argentina.

Other income (expense) - net was income of $35 million in the second quarter of 2019, compared to income of $22 million in the second quarter of 2018. The increase was primarily due to higher income earned from financial services activities.

Segment EBIT increased by $76 million to $182 million in the second quarter of 2019 from $106 million in the second quarter of 2018. The increase was primarily due to a more favorable foreign exchange result, lower SG&A expenses and higher income earned from financial services, partially offset by overall lower gross profit.

Edible Oil Products Segment - Edible Oil Products segment net sales decreased by 5% in the second quarter of 2019 to $2.2 billion, compared to $2.3 billion in the second quarter of 2018. The decrease was primarily due to lower prices in Europe, Asia and Brazil, partially offset by higher volumes in all regions.
Cost of goods sold in the second quarter of 2019 decreased 6% from the same period of 2018, which is substantially in line with the decrease in net sales noted above.


41

Table of Contents

Gross profit in the second quarter of 2019 increased by 15% to $142 million compared to $123 million for the second quarter of 2018. The increase was primarily due to improved results in South America, from higher margins on packaged oils in Brazil driven by tighter supply and lower industrial costs and in Argentina from higher volumes and a favorable product mix, and in North America from higher volumes and margins.

SG&A expenses decreased slightly to $113 million in the second quarter of 2019 compared with $114 million in the same period a year ago.

Segment EBIT increased to $25 million for the second quarter of 2019 from $11 million in the second quarter of 2018, primarily associated with higher gross profit.

Milling Products Segment - Milling Products segment net sales were $430 million in the second quarter of 2019, compared to $426 million for the same period a year ago. The increase was primarily driven by Brazil, resulting from increased prices for wheat products and in the U.S. on higher export volumes in our rice milling business. These increases were partially offset by lower volumes in Mexico.

Cost of goods sold increased by 7% to $389 million for the second quarter of 2019 from $363 million in the second quarter of 2018. In addition to higher costs of raw materials in Brazil, the increase was due to an impairment charge associated with our extrusion business in the U.S. These increases were partially offset by lower volumes in Mexico.

Gross profit decreased to $41 million in the second quarter of 2019, compared to $63 million in the second quarter of 2018. The decrease was primarily associated with lower margins in Brazil due to strong price competition and in Mexico due to soft demand and increased competition, as well as the above-mentioned impairment charge associated with our extrusion business.

SG&A expenses of $34 million in the second quarter of 2019 increased by $1 million compared to the same period in 2018.

Other income (expense) - net was income of $9 million in the second quarter of 2019, compared to a loss of $2 million in the second quarter of 2018. The increase was primarily due to a gain on an arbitration settlement in the U.S. in 2019.

Segment EBIT was $17 million in the second quarter of 2019, compared to $26 million last year. The decrease was primarily due to lower gross profit in Brazil and Mexico and an impairment charge, partially offset by a gain on an arbitration settlement in the U.S.

Sugar and Bioenergy Segment - Sugar and Bioenergy segment net sales decreased 51% to $284 million in the second quarter of 2019 compared to $582 million in the same quarter last year. The decrease in sales was primarily due to exiting our international trading and merchandising business in 2018, as well as lower volumes and global prices of sugar, partially offset by higher volumes and prices in ethanol.

Cost of goods sold decreased 52% in the second quarter of 2019 compared to the same period of 2018, which is substantially in line with the decrease in net sales. Additionally, depreciation and depletion contributed to the lower cost of goods sold.

Gross profit increased $2 million to $4 million in the second quarter of 2019 from $2 million in 2018, primarily associated with higher ethanol sales volumes and lower costs.

SG&A expenses of $15 million in the second quarter of 2019 decreased by $30 million from $45 million in the same period of 2018, primarily associated with higher bad debt expenses in 2018, the exit of the international trading and merchandising business, and the impact of the depreciation of the Brazilian real against the U.S. dollar.

Foreign exchange results in the second quarter of 2019 were gains of $1 million, compared to losses of $4 million in the second quarter of 2018. Foreign exchange results are primarily driven by funding non-U.S. functional currency operations.

Other income (expense) - net was a loss of $2 million in the second quarter of 2019, compared to a loss of $15 million in the second quarter of 2018. Results in 2018 included a $16 million loss related to the sale of an equity investment.

42

Table of Contents


Segment EBIT was a loss of $11 million in the second quarter of 2019 compared to a loss of $63 million in the second quarter of 2018. The improved results were primarily associated with significantly lower SG&A costs in 2019 and improved ethanol results. Additionally, results in 2018 were impacted by a loss related to the sale of an equity investment.

Fertilizer Segment - Fertilizer segment net sales were $108 million in the second quarter of 2019 compared to $89 million in the second quarter of 2018. The increase was primarily due to higher volumes and sales prices in Argentina.

Cost of goods sold increased to $97 million in the second quarter of 2019, from $89 million in the second quarter of 2018, primarily due to higher volumes. Additionally, 2018 costs were impacted by unfavorable foreign currency translation.

Gross profit was $11 million in the second quarter of 2019 compared to $0 million in the comparable period of 2018 mainly due to higher volumes and improved margins.

SG&A expenses were $4 million in the second quarter of 2019, compared to $7 million in the comparable period of 2018. The decrease was primarily due to bad debt recoveries in 2019 and the depreciation of the Brazilian real against the U.S. dollar.
    
Segment EBIT increased by $15 million to $6 million in the second quarter of 2019 as compared to a loss of $9 million in the same period a year ago. The increase was primarily due to higher gross profit and lower overall expenses.

Other - Other segment EBIT of $135 million in the second quarter of 2019 relates to the results of our corporate venture capital unit, which benefited from the initial public offering of one of its investments during the second quarter of 2019 and subsequent unrealized mark-to-market gains.
 
Interest - A summary of consolidated interest income and expense follows:
 
 
Three Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
Interest income
 
$
7

 
$
6

Interest expense
 
(88
)
 
(94
)

Interest income increased to $7 million in the second quarter of 2019 compared to $6 million in the second quarter of 2018. Interest expense decreased by $6 million compared to 2018, primarily due to overall lower average debt levels.

Six Months Ended June 30, 2019 Compared to Six Months Ended June 30, 2018
Net Income (Loss) Attributable to Bunge - For the six months ended June 30, 2019, net income attributable to Bunge increased by $292 million to $259 million from a loss of $33 million in the six months ended June 30, 2018. This increase resulted primarily from an increase in segment EBIT from our reportable segments of $238 million, predominantly in Agribusiness, Edible Oils, and Sugar and Bioenergy, as well as $135 million of EBIT associated with our corporate venture capital unit, partially offset by higher associated income tax expense. Segment EBIT also benefited from SG&A savings associated with the GCP.
Income Tax Expense - For the six months ended June 30, 2019, income tax expense related to continuing operations was $98 million, compared to $21 million for the six months ended June 30, 2018. The higher income tax expense for the six months ended June 30, 2019 compared to the same period last year is primarily due to higher overall pretax income. The effective tax rate for the six months ended June 30, 2019 was 27%. The effective tax rate for the six months ended June 30, 2018 was significantly impacted by a small pretax loss.
A summary of certain items in our condensed consolidated statements of income and volumes by reportable segment for the periods indicated is set forth below.
 
 
Six Months Ended
June 30,
(US$ in millions, except volumes)
 
2019
 
2018
Volumes (in thousands of metric tons):
 
 

 
 


43

Table of Contents

Agribusiness
 
68,438

 
73,203

Edible oil products
 
4,637

 
4,269

Milling products
 
2,218

 
2,312

Sugar and Bioenergy
 
1,644

 
3,017

Fertilizer
 
501

 
426

 
 
 
 
 
Net sales:
 
 

 
 

Agribusiness
 
$
13,987

 
$
16,187

Edible oil products
 
4,445

 
4,474

Milling products
 
856

 
835

Sugar and Bioenergy
 
569

 
1,145

Fertilizer
 
177

 
147

Total
 
$
20,034

 
$
22,788

 
 
 
 
 
Cost of goods sold:
 
 

 
 

Agribusiness
 
$
(13,438
)
 
$
(15,630
)
Edible oil products
 
(4,153
)
 
(4,225
)
Milling products
 
(766
)
 
(718
)
Sugar and Bioenergy
 
(567
)
 
(1,147
)
Fertilizer
 
(161
)
 
(142
)
Total
 
$
(19,085
)
 
$
(21,862
)
 
 
 
 
 
Gross profit:
 
 

 
 

Agribusiness
 
$
549

 
$
557

Edible oil products
 
292

 
249

Milling products
 
90

 
117

Sugar and Bioenergy
 
2

 
(2
)
Fertilizer
 
16

 
5

Total
 
$
949

 
$
926

 
 
 
 
 
Selling, general and administrative expenses:
 
 

 
 

Agribusiness
 
$
(309
)
 
$
(363
)
Edible oil products
 
(212
)
 
(205
)
Milling products
 
(67
)
 
(72
)
Sugar and Bioenergy
 
(33
)
 
(69
)
Fertilizer
 
(7
)
 
(12
)
Other
 
(12
)
 

Total
 
$
(640
)
 
$
(721
)
 
 
 
 
 
Foreign exchange gains (losses):
 
 

 
 

Agribusiness
 
$
(18
)
 
$
(93
)
Edible oil products
 
(1
)
 
4

Milling products
 
3

 

Sugar and Bioenergy
 
(2
)
 
(3
)
Fertilizer
 

 
(4
)
Total
 
$
(18
)
 
$
(96
)
 
 
 
 
 

44

Table of Contents

EBIT attributable to noncontrolling interests:
 
 

 
 

Agribusiness
 
$
2

 
$
1

Edible oil products
 
(6
)
 
(5
)
Milling products
 

 

Sugar and Bioenergy
 

 

Fertilizer
 

 
(1
)
Total
 
$
(4
)
 
$
(5
)
 
 
 
 
 
Other income (expense) - net:
 
 

 
 

Agribusiness (1)
 
$
67

 
$
46

Edible oil products
 

 
(4
)
Milling products
 
8

 
(2
)
Sugar and Bioenergy
 
(2
)
 
(13
)
Fertilizer
 
(2
)
 
1

Other
 
147

 

Total
 
$
218

 
$
28

 
 
 
 
 
Segment EBIT:
 
 
 
 
Agribusiness
 
$
291

 
$
148

Edible oil products
 
73

 
39

Milling products
 
34

 
43

Sugar and Bioenergy
 
(35
)
 
(87
)
Fertilizer
 
7

 
(11
)
Other
 
135

 

Total
 
$
505

 
$
132

A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
 
 
Six Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
Net income (loss) attributable to Bunge
 
$
259

 
$
(33
)
Interest income
 
(14
)
 
(14
)
Interest expense
 
163

 
164

Income tax expense (benefit)
 
98

 
21

(Income) loss from discontinued operations, net of tax
 

 
(5
)
Noncontrolling interest's share of interest and tax
 
(1
)
 
(1
)
Total Segment EBIT
 
$
505

 
$
132


Agribusiness Segment - Agribusiness segment net sales decreased by 14% to $14.0 billion in the six months ended June 30, 2019, compared to $16.2 billion in the six months ended June 30, 2018. The decrease was primarily due to lower volumes in our grain origination and distribution businesses, associated with lower supply in North America due to severe weather conditions, slow farmer selling in Brazil, as well as on average lower prices in our oilseed businesses due to increased global soybean meal availability, partly driven by increased supply in Argentina following last year’s drought, and lower demand from China as a result of the African swine fever outbreak.

Cost of goods sold decreased by 14%, primarily in our grain origination and grain trading and distribution businesses, related to lower volumes and prices as discussed above.

Gross profit decreased by $8 million to $549 million in the six months ended June 30, 2019, from $557 million in the six months ended June 30, 2018. The decrease was primarily due to lower results in our grain origination, and grain

45

Table of Contents

trading and distribution businesses driven by lower volumes and margins in all regions, lower oilseed processing results in Argentina and Brazil, and lower oilseed trading and distribution results. Partially offsetting these lower results were higher results in oilseed processing in the U.S., Europe, and China, driven by the hedging of soy crush margins at the higher levels during the second half of last year, improved results in our softseed processing businesses in Europe and Canada due to higher margins, as well as improved results in our ocean freight business.
 
SG&A expenses decreased $54 million to $309 million in the six months ended June 30, 2019, which represented a 15% decrease from the $363 million in the same period last year. The decrease was mainly due to savings from the GCP, as well as lower charges recognized in the first six months of 2019 associated with execution of the GCP as compared to the same period last year, and from the depreciation of the Brazilian real against the U.S. dollar.
 
Foreign exchange results in the six months ended June 30, 2019 were losses of $18 million, compared to losses of $93 million in the six months ended June 30, 2018. Foreign exchange results are primarily driven by funding non-U.S. functional currency operations. Results in 2018 were primarily driven by the devaluation of the Argentine peso on U.S. dollar loans to fund operations in Argentina.

Other income (expense) - net was income of $67 million in the six months ended June 30, 2019, compared to income of $46 million in the six months ended June 30, 2018. The increase was primarily due higher income earned from financial services activities and improved results from our soy crush equity method investments in Asia and South America.

Segment EBIT increased by $143 million to $291 million in the six months ended June 30, 2019 from $148 million in the six months ended June 30, 2018. The increase was primarily due to higher oilseed processing results in Europe, China and Canada, better results from ocean freight, lower foreign exchange losses, and lower SG&A expenses, partially offset by lower results in our grain businesses and oilseed trading and distribution businesses.

Edible Oil Products Segment - Edible oil products segment net sales decreased by 1% in the six months ended June 30, 2019 to $4.4 billion, compared to $4.5 billion in the six months ended June 30, 2018, resulting primarily from lower prices in the U.S., Europe, and Brazil, partially offset by an increase in volumes driven by our acquisition of Loders on March 1, 2018.

Cost of goods sold in the six months ended June 30, 2019 decreased 2% from the same period of 2018, which is substantially in line with the decrease in net sales noted above.

Gross profit in the six months ended June 30, 2019 increased to $292 million compared to $249 million for the six months ended June 30, 2018. The increase was primarily due to the acquisition of Loders and improved results in South America, from higher margins on packaged oils in Brazil compared to the prior year due to excess supplies in 2018, in Argentina from higher volumes and a favorable product mix, and the U.S. from higher volumes and margins.

SG&A expenses increased by 3% to $212 million in the six months ended June 30, 2019 compared with $205 million in the same period a year ago. The increase was related to the acquisition of Loders, partially offset by lower costs in Europe and Brazil due to the depreciation of the euro and Brazilian real against the U.S. dollar, as well as savings from the GCP across all regions.

Segment EBIT increased to $73 million for the six months ended June 30, 2019, up from $39 million in the six months ended June 30, 2018. The increase was primarily due to the acquisition of Loders, higher gross profit in South America and the U.S. and lower SG&A costs in Europe and Brazil.

Milling Products Segment - Milling products segment net sales were $856 million in the six months ended June 30, 2019, compared to $835 million. The increase was primarily driven by higher prices for wheat products in Brazil and from the acquisition of two corn mills in the U.S. ("Minsa") in the first quarter of 2018. These increases were partially offset by lower volumes in Brazil and Mexico.

Cost of goods sold increased by 7% to $766 million for the six months ended June 30, 2019 from $718 million in the six months ended June 30, 2018. The increase was primarily due to the higher cost of raw materials in Brazil, the impairment charge associated with our extrusion business in the U.S., and additional costs associated with the acquisition of Minsa. These increases were partially offset by lower volumes in Mexico.


46

Table of Contents

Gross profit decreased to $90 million in the six months ended of 2019, down from $117 million in the six months ended June 30, 2018. The decrease was primarily associated with lower volumes and margins in Brazil and Mexico, as well as the above-mentioned impairment charge associated with our extrusion business.

SG&A expenses decreased to $67 million in the six months ended June 30, 2019 from $72 million. The decrease was primarily due to savings from the GCP and the depreciation of the Brazilian real against the U.S. dollar. Additionally, 2018 was impacted by acquisition costs related to Minsa.

Other income (expense) - net was income of $8 million in the six months ended June 30, 2019, compared to a loss of $2 million in the six months ended June 30, 2018. The increase was primarily due to a gain on an arbitration settlement in the U.S. in 2019.

Segment EBIT decreased to $34 million in the six months ended June 30, 2019, from $43 million in the six months ended June 30, 2018. The decrease was primarily due to lower gross profit in Brazil and Mexico and an impairment charge, partially offset by the arbitration settlement gain and lower SG&A expenses.

Sugar and Bioenergy Segment - Sugar and Bioenergy segment net sales decreased to $569 million in the six months ended June 30, 2019 compared to $1.1 billion in the same period last year. The 50% decrease in sales was primarily due to exiting our international trading and merchandising business in 2018, as well as lower global prices and volume of sugar, partially offset by higher prices and volumes of ethanol.

Cost of goods sold decreased 51% in the six months ended June 30, 2019 compared to the same period June 30, 2018, which is in line with lower net sales.

Gross profit increased to $2 million in the six months ended June 30, 2019 from a loss of $2 million in the six months ended June 30, 2018, primarily associated with higher ethanol prices and sales volumes and lower industrial costs.

SG&A expenses decreased by 52% to $33 million in the six months ended June 30, 2019 from $69 million in the comparable period June 30, 2018, primarily associated the exit of the international trading and merchandising business, lower bad debt expenses, savings and lower costs associated with the GCP, and the impact of the depreciation of the Brazilian real against the U.S. dollar.

Foreign exchange results in the six months ended June 30, 2019 were losses of $2 million compared to losses of $3 million in the six months ended June 30, 2018. Foreign exchange results are primarily driven by funding non-U.S. functional currency operations.

Other income (expense) - net was a loss of $2 million in the six months ended June 30, 2019, compared to a loss of $13 million in the six months ended June 30, 2018. Results in 2018 included a $16 million loss related to the sale of an equity investment.

Segment EBIT improved to a loss of $35 million in the six months ended June 30, 2019 from a loss of $87 million in the six months ended June 30, 2018. The better results were primarily associated with improved gross profit and significantly lower SG&A costs in 2019. Results in 2018 were impacted by a loss related to the sale of an equity investment.

Fertilizer Segment - Fertilizer segment net sales increased 20% to $177 million in the six months ended June 30, 2019, compared to $147 million in the six months ended June 30, 2018. The increase was primarily due to higher volumes and prices in Argentina.

Cost of goods sold for the six months ended June 30, 2019 were $161 million, compared to $142 million for the six months ended June 30, 2018. The increase was primarily due to higher volumes. Additionally, 2018 costs were impacted by unfavorable foreign currency translation.

Gross profit increased by $11 million to $16 million in the six months ended June 30, 2019, from $5 million in the comparable period June 30, 2018, due to higher volumes and lower costs, and the impact of favorable foreign currency translation compared to the prior year.

SG&A expenses decreased by $5 million to $7 million in the six months ended June 30, 2019, from $12 million in the comparable period June 30, 2018. The decrease was primarily due to bad debt recoveries during 2019.

47

Table of Contents


Segment EBIT improved by $18 million to $7 million in the six months ended June 30, 2019 from a loss of $11 million in the same period a year ago. The increase was primarily due to higher gross profit, lower overall expenses, and better foreign exchange results.

Other - Other segment EBIT of 135 million in the six months ended June 30, 2019 relates to the operations of our corporate venture capital unit, which benefited from the initial public offering of one of its investments during the second quarter of 2019 and subsequent unrealized mark-to-market gains.

Interest - A summary of consolidated interest income and expense follows:
 
 
Six Months Ended
June 30,
(US$ in millions)
 
2019
 
2018
Interest income
 
$
14

 
$
14

Interest expense
 
(163
)
 
(164
)

Interest income was $14 million in the six months ended June 30, 2019 and 2018. Interest expense decreased by $1 million compared to 2018 as lower overall average debt balances were partially offset by higher interest rates in certain countries.
Liquidity and Capital Resources
Liquidity
Our main financial objectives are to prudently manage financial risks, ensure consistent access to liquidity and minimize cost of capital in order to efficiently finance our business and maintain balance sheet strength. We generally finance our ongoing operations with cash flows generated from operations, issuance of commercial paper, borrowings under various bilateral and syndicated revolving credit facilities, term loans and proceeds from the issuance of senior notes. Acquisitions and long-lived assets are generally financed with a combination of equity and long-term debt.
Our current ratio, which is a widely used measure of liquidity and is defined as current assets divided by current liabilities, was 1.49 and 1.54 at June 30, 2019 and December 31, 2018, respectively.
Cash and Cash Equivalents - Cash and cash equivalents were $238 million and $389 million at June 30, 2019 and December 31, 2018, respectively. Cash balances are managed in accordance with our investment policy, the objectives of which are to preserve the principal value of our cash assets, maintain a high degree of liquidity and deliver competitive returns subject to prevailing market conditions. Cash balances are typically invested in short term deposits with highly-rated financial institutions and in U.S. government securities.
Readily Marketable Inventories (“RMI”) - RMI are agricultural commodity inventories such as soybeans, soybean meal, soybean oil, corn, wheat and sugar that are readily convertible to cash because of their commodity characteristics, widely available markets and international pricing mechanisms. Total RMI reported at fair value were $4,423 million and $4,532 million at June 30, 2019 and December 31, 2018, respectively (see Note 6 - Inventories, to our condensed consolidated financial statements).
Financing Arrangements and Outstanding Indebtedness - We conduct most of our financing activities through a centralized financing structure that provides the company efficient access to debt and capital markets. This structure includes a master trust, the primary assets of which consist of intercompany loans made to Bunge Limited and its subsidiaries. Certain of Bunge Limited’s 100% owned finance subsidiaries, Bunge Limited Finance Corp., Bunge Finance Europe B.V. and Bunge Asset Funding Corp., fund the master trust with short and long-term debt obtained from third parties, including through our commercial paper program and certain credit facilities, as well as the issuance of senior notes. Borrowings by these finance subsidiaries carry full, unconditional guarantees by Bunge Limited.
Revolving Credit Facilities - At June 30, 2019, we had approximately $5,015 million of aggregate committed borrowing capacity under our commercial paper program and various revolving bilateral and syndicated credit facilities, of

48

Table of Contents

which $4,221 million was unused and available. The following table summarizes these facilities as of the periods presented:
(US$ in millions)
 
 
 
Total Committed
Capacity
 
Borrowings Outstanding
Commercial Paper Program
and Revolving Credit Facilities
 
Maturities
 
June 30,
2019
 
June 30,
2019
 
December 31,
2018
Commercial paper
 
2023
 
$
600

 
$
544

 
$

Long-term revolving credit facilities (1)
 
2020 - 2023
 
$
4,415

 
250

 
500

Total
 
 
 
$
5,015

 
$
794

 
$
500

 
(1) 
Borrowings under the revolving credit facilities that have maturities greater than one year from the date of the condensed consolidated balance sheets are classified as long-term debt, consistent with the long-term maturity of the underlying facilities. However, individual borrowings under the revolving credit facilities are generally short-term in nature, bear interest at variable rates and can be repaid or renewed as each such individual borrowing matures.
We had no borrowings outstanding at June 30, 2019 under our unsecured $1,100 million five-year syndicated revolving credit agreement (the "Credit Agreement") with certain lenders party thereto maturing December 14, 2023. We have the option to request an extension of the maturity date of the Credit Agreement for two additional one-year periods, subject to the consent of the lenders. Borrowings under the Credit Agreement will bear interest at LIBOR plus a margin, which will vary from 1.00% to 1.625%, based on the credit ratings of our senior long-term unsecured debt ("Rating Level"). Amounts under the Credit Agreement that remain undrawn are subject to a commitment fee at rates ranging from 0.09% to 0.225%, varying based on the Rating Level. We may, from time to time, request one or more of the existing lenders or new lenders to increase the total commitments under the Credit Agreement by up to $200 million pursuant to an accordion provision.
We had $250 million of borrowings outstanding at June 30, 2019 under our $1,750 million unsecured syndicated revolving credit facility with certain lenders party thereto maturing December 12, 2020 (the ‘‘2020 Facility’’). Borrowings under the 2020 Facility bear interest at LIBOR plus a margin, which will vary from 0.30% to 1.30% per annum, based on the credit ratings of our senior long-term unsecured debt. We also pay a fee that varies from 0.10% to 0.40% per annum, based on the utilization of the 2020 Facility. Amounts under the 2020 Facility that remain undrawn are subject to a commitment fee payable quarterly in arrears at a rate of 35% of the margin specified above, which varies based on the rating level at each quarterly payment date. We may, from time to time, with the consent of the facility agent, request one or more of the existing lenders or new lenders to increase the total commitments under the 2020 Facility by up to $250 million pursuant to an accordion provision. We have the option to request an extension of the maturity date of the 2020 Facility for two additional one-year periods. Each lender in its sole discretion may agree to any such extension request.
We had no borrowings outstanding at June 30, 2019 under our unsecured $865 million revolving credit facility, maturing September 6, 2022 (the "2022 Facility"). Borrowings under the 2022 Facility bear interest at LIBOR plus a margin, which will vary from 1.00% to 1.75% per annum, based on the credit ratings of our senior long-term unsecured debt. Amounts under the 2022 Facility that remain undrawn are subject to a commitment fee payable quarterly based on the average undrawn portion of the 2022 Facility at rates ranging from 0.125% to 0.275%, based on the credit ratings of our senior long-term unsecured debt.
We had no borrowings outstanding at June 30, 2019 under our unsecured $700 million, 5-year revolving credit facility, maturing on May 1, 2023. Additionally, subject to lender approval, we may request an increase, in an amount not to exceed $100 million, to the revolving credit facility commitments pursuant to an accordion provision. We entered into this facility in connection with our previously announced strategy to reduce our exposure to the sugar milling business in Brazil. This facility is upon fulfillment of certain conditions convertible into a non-recourse secured term loan facility with our sugar milling business as the borrower, and therewith providing financial flexibility for us to fund our sugar milling business on a stand-alone basis. In connection with the previously announced agreement to form of a joint venture relating to our Brazilian sugar and bioenergy operations, we intend to convert this facility on or prior to the closing of the joint venture transaction (See Note 21, Subsequent Event, to our condensed consolidated financial statements). 
Our commercial paper program is supported by committed back-up bank credit lines (the ‘‘Liquidity Facility’’) equal to the amount of the commercial paper program provided by lending institutions that are required to be rated at least A-1 by Standard & Poor’s and P-1 by Moody’s Investor Services. The cost of borrowing under the Liquidity Facility would typically be higher than the cost of issuance under our commercial paper program. At June 30, 2019, $544 million of borrowings were outstanding under the commercial paper program and no borrowings were outstanding under the Liquidity Facility. The Liquidity Facility is our only revolving credit facility that requires lenders to maintain minimum credit ratings.

49

Table of Contents

In addition to committed credit facilities, from time to time, through our financing subsidiaries, we enter into bilateral short-term credit lines as necessary based on our financing requirements. At June 30, 2019 there were $450 million of borrowings outstanding under these bilateral short-term credit lines.
Short and long-term debt - Our short and long-term debt increased by $976 million at June 30, 2019 from December 31, 2018, primarily due to the funding of working capital requirements. For the six months ended June 30, 2019, our average short and long-term debt outstanding was approximately $6,159 million compared to approximately $6,614 million for the six months ended at June 30, 2018. Our long-term debt balance was $4,463 million at June 30, 2019 compared to $4,622 million at December 31, 2018. The following table summarizes our short-term debt at June 30, 2019.
(US$ in millions)
 
Outstanding
Balance at June 30, 2019
 
Weighted Average
Interest Rate at
June 30, 2019
 
Highest Balance
Outstanding During
Quarter Ended June 30, 2019
 
Average Balance
During Quarter Ended June 30, 2019
 
Weighted Average
Interest Rate
During Quarter Ended March 31, 2019
Bank borrowings (1)
 
$
1,341

 
4.98
%
 
$
1,579

 
$
1,367

 
5.83
%
Commercial paper
 
544

 
2.79
%
 
599

 
511

 
2.88
%
Total
 
$
1,885

 


 
$
2,178

 
$
1,878

 


 
(1)
Includes $155 million of local currency bank borrowings in certain Central and Eastern European, South American, and Asia Pacific countries at a weighted average interest rate of 18.19% as of June 30, 2019.

The following table summarizes our short and long-term indebtedness:
(US$ in millions)
 
June 30,
2019

December 31,
2018
Short-term debt: (1)
 
20

 
 

Short-term debt (2)
 
$
1,885

 
$
750

Current portion of long-term debt
 
424

 
419

Total short-term debt
 
2,309

 
1,169

 
 
 
 
 
Long-term debt (3):
 
 

 
 

Revolving credit facility expiry 2020
 
250

 
500

Term loan due 2019 - three-month Yen LIBOR plus 0.75% (Tranche A)
 
265

 
258

Term loan due 2019 - fixed Yen interest rate of 0.96% (Tranche B)
 
56

 
54

Term loan due 2019 - three-month LIBOR plus 1.30% (Tranche C)
 
85

 
85

3.50% Senior Notes due 2020
 
499

 
498

3.00% Senior Notes due 2022
 
398

 
397

1.85% Senior Notes due 2023 - Euro
 
910

 
916

4.35% Senior Notes due 2024
 
595

 
595

3.25% Senior Notes due 2026
 
695

 
695

3.75% Senior Notes due 2027
 
594

 
594

Other
 
116

 
30

Subtotal
 
4,463

 
4,622

Less: Current portion of long-term debt
 
(424
)
 
(419
)
Total long-term debt
 
4,039

 
4,203

Total debt
 
$
6,348

 
$
5,372

 
(1) 
Includes secured debt of $4 million and $9 million at June 30, 2019 and December 31, 2018, respectively.

50

Table of Contents

(2) 
Includes $155 million and $136 million of local currency bank borrowings in certain Central and Eastern European, South American and Asia-Pacific countries at a weighted average interest rate of 18.19% and 23.61% as of June 30, 2019 and December 31, 2018, respectively.
(3) 
Includes secured debt of $16 million and $17 million at June 30, 2019 and December 31, 2018, respectively.
Credit Ratings Bunge’s debt ratings and outlook by major credit rating agencies at June 30, 2019 was as follows:
 
 
Short-term
Debt (1)
 
Long-term
Debt
 
Outlook
Standard & Poor’s
 
A-1
 
BBB
 
Negative
Moody’s
 
P-1
 
Baa3
 
Stable
Fitch
 
F1
 
BBB-
 
Stable
 
(1)
Short-term debt rating applies only to Bunge Asset Funding Corp., the issuer under our commercial paper program.
Our debt agreements do not have any credit rating downgrade triggers that would accelerate maturity of our debt. However, credit rating downgrades would increase our borrowing costs under our syndicated credit facilities and, depending on their severity, could impede our ability to obtain credit facilities or access the capital markets in the future on competitive terms. A significant increase in our borrowing costs could impair our ability to compete effectively in our business relative to competitors with higher credit ratings.
Our credit facilities and certain senior notes require us to comply with specified financial covenants including minimum net worth, minimum current ratio, a maximum debt to capitalization ratio and limitations on secured indebtedness. We were in compliance with these covenants as of June 30, 2019.
On July 1, 2019, we entered into an unsecured five-year multi-currency syndicated term loan agreement (the "Term Loan") in the Japanese loan market, with certain lenders party thereto. The Term Loan is comprised of two tranches: Tranche A, Japanese Yen 30.7 billion ($285 million) bearing interest at three-month LIBOR plus a margin of 0.75% and Tranche B, $90 million bearing interest at three-month LIBOR plus a margin of 1.30%. The proceeds were used to pre-pay amounts outstanding under our existing multi-currency syndicated term loan facility in the Japanese loan market maturing in December 2019.
Trade Receivable Securitization Program - We participate in a trade receivable securitization program (the "Program"), which provides us with an additional source of liquidity. The Program terminates on May 26, 2021, however, each committed purchaser's commitment to fund trade receivables sold under the Program would have terminated on May 26, 2019 unless extended in accordance with the terms of the receivables transfer agreement. On February 19, 2019, we extended the committed purchasers' commitments to fund trade accounts receivables under the Program until May 26, 2020 and exercised a portion of the $300 million accordion feature under the Program to increase the aggregate size of the facility by $100 million to an aggregate of $800 million.
Equity
Total equity is set forth in the following table:
(US$ in millions)
 
June 30,
2019

December 31, 2018
Equity:
 
 

 
 

Convertible perpetual preference shares
 
$
690

 
$
690

Common shares
 
1

 
1

Additional paid-in capital
 
5,300

 
5,278

Retained earnings
 
8,179

 
8,059

Accumulated other comprehensive income
 
(6,919
)
 
(6,935
)
Treasury shares, at cost - 2019 and 2018 - 12,882,313 shares
 
(920
)
 
(920
)
Total Bunge shareholders’ equity
 
6,331

 
6,173

Noncontrolling interest
 
194

 
205

Total equity
 
$
6,525

 
$
6,378


51

Table of Contents

Total Bunge shareholders’ equity was $6,331 million at June 30, 2019 compared to $6,173 million at December 31, 2018. The increase during the six months ended June 30, 2019 was primarily due to $259 million of net income attributable to Bunge and $70 million cumulative translation gains, partially offset by $31 million of losses associated with hedging activities and $142 million and $17 million of declared dividends to common and preferred shareholders, respectively.
Noncontrolling interest decreased to $194 million at June 30, 2019 from $205 million at December 31, 2018. The decrease during the six months ended June 30, 2019 was primarily due to dividends paid to noncontrolling interest entities.
As of June 30, 2019, we had 6,899,683 of 4.875% cumulative convertible perpetual preference shares outstanding with an aggregate liquidation preference of $690 million. Each convertible perpetual preference share has an initial liquidation preference of $100, which will be adjusted for any accumulated and unpaid dividends. The convertible perpetual preference shares carry an annual dividend of $4.875 per share payable quarterly. As a result of adjustments made to the initial conversion price because cash dividends paid on Bunge Limited’s common shares exceeded certain specified thresholds, each convertible perpetual preference share is convertible, at the holder’s option, at any time into 1.2072 Bunge Limited common shares, based on the conversion price of $82.8357 per share, subject to certain additional anti-dilution adjustments (which represents 8,329,297 Bunge Limited common shares at June 30, 2019). At any time, if the closing price of our common shares equals or exceeds 130% of the conversion price for 20 trading days during any consecutive 30 trading days (including the last trading day of such period), we may elect to cause the convertible perpetual preference shares to be automatically converted into Bunge Limited common shares at the then-prevailing conversion price. The convertible perpetual preference shares are not redeemable by us at any time.
Cash Flows
Our cash flows from operations vary depending on, among other items, the market prices and timing of the purchase and sale of our inventories. Generally, during periods when commodity prices are rising, our Agribusiness operations require increased use of cash to support working capital to acquire inventories and fund daily settlement requirements on exchange traded futures that we use to minimize price risk related to the purchase and sale of our inventories.
For the six months ended June 30, 2019, our cash and cash equivalents and restricted cash decreased by $145 million, compared to a decrease of $380 million in cash and cash equivalents and restricted cash for the six months ended June 30, 2018.
Cash used for operating activities was $1,083 million for the six months ended June 30, 2019 compared to $3,549 million for the six months ended June 30, 2018. Net cash outflows for operating activities was lower for the six months ended June 30, 2019, primarily due to lower working capital requirements, the lower use of cash associated with beneficial interests in securitized trade receivables, and higher net income compared to the six months ended June 30, 2018.
Certain of our non-U.S. operating subsidiaries are primarily funded with U.S. dollar-denominated debt, while currency risk is hedged with U.S. dollar-denominated assets. The functional currency of our operating subsidiaries is generally the local currency. The financial statements of our subsidiaries are calculated in the functional currency, and when the local currency is the functional currency, translated into U.S. dollar. U.S. dollar-denominated loans are remeasured into their respective functional currencies at exchange rates at the applicable balance sheet date. Also, certain of our U.S. dollar functional operating subsidiaries outside the U.S. are partially funded with local currency borrowings, while the currency risk is hedged with local currency denominated assets. Local currency loans in U.S. dollar functional currency subsidiaries outside the U.S. are remeasured into U.S. dollars at the exchange rate on the applicable balance sheet date. The resulting gain or loss is included in our condensed consolidated statements of income as foreign exchange gains or losses. For the six months ended June 30, 2019 and 2018, we recorded foreign currency losses on our debt of $38 million and $171 million, respectively, which were included as adjustments to reconcile net income to cash used for operating activities in the line item “Foreign exchange loss on net debt” in our condensed consolidated statements of cash flows. This adjustment is required as these losses are non-cash items that arise from financing activities and therefore will have no impact on cash flows from operations.
Cash provided by investing activities was $185 million in the six months ended June 30, 2019 compared to cash used for investing activities of $217 million in the six months ended June 30, 2018. For the six months ended June 30, 2019, payments were made for capital expenditures of $265 million, primarily related to replanting of sugarcane for our industrial sugar business in Brazil, as well as other capital projects at various facilities. In addition, payments were made for investments of $277 million, primarily related to deposits in South America and promissory notes related to financial services, which were partially offset by proceeds from such investments of $213 million. Cash provided by investing activities was primarily associated with proceeds of $547 million from beneficial interests in securitized trade receivables. For the six months ended June 30, 2018, payments made for capital expenditures were $220 million, primarily related to replanting of sugarcane for our industrial sugar business in Brazil and the upgrade of our crush facility in Italy, as well as other capital projects at various facilities. In addition, we acquired Loders for $895 million, net of cash acquired and Minsa for $73 million, net of cash acquired. Further, payments were made for investments of $1,082 million, primarily related to deposits, treasuries and bonds in South America related to financial services activities, which were partially offset by proceeds from such investments of $945

52

Table of Contents

million. These payments were additionally offset by proceeds of $1,064 million from beneficial interests in securitized trade receivables.
Cash provided by financing activities was $745 million in the six months ended June 30, 2019, compared to $3,418 million in the six months ended June 30, 2018. In the six months ended June 30, 2019, the net increase of $904 million in borrowings was primarily related to the funding of working capital needs and to finance capital expenditures. In addition, we paid dividends of $158 million to our common shareholders and holders of our convertible preference shares. In the six months ended June 30, 2018, the net increase of $3,567 million in borrowings was primarily related to the funding of acquisitions, higher working capital needs, and to finance capital expenditures. In addition, we paid dividends of $147 million to our common shareholders and holders of our convertible preference shares.
Off-Balance Sheet Arrangements
Guarantees - We have issued or were a party to the following guarantees at June 30, 2019:
(US$ in millions)
 
Maximum
Potential
Future
Payments
Unconsolidated affiliates guarantee (1)(2)
 
$
310

Residual value guarantee (3)
 
260

Total
 
$
570

 
(1) 
We have issued guarantees to certain financial institutions related to debt of certain of our unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings which have maturity dates through 2034. There are no recourse provisions or collateral that would enable us to recover any amounts paid under these guarantees. In addition, one of our subsidiaries has guaranteed the obligations of two of its affiliates and in connection therewith has secured its guarantee obligations through a pledge of one of its affiliate's shares plus loans receivable from the affiliate to the financial institutions in the event that the guaranteed obligations are enforced. Based on the amounts drawn under such debt facilities at June 30, 2019, our potential liability was $159 million, and we have recorded a $18 million obligation related to these guarantees.
(2) 
We have issued guarantees to certain third parties related to performance of our unconsolidated affiliates. The terms of the guarantees are equal to the completion date of a port terminal which is expected to be completed in 2020. There are no recourse provisions or collateral that would enable us to recover any amounts paid under these guarantees. At June 30, 2019, Bunge's maximum potential future payments under these guarantees was $59 million, and no obligation has been recorded related to these guarantees.
(3) 
We have issued guarantees to certain financial institutions which are party to certain operating lease arrangements for railcars and barges. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2019 through 2024. At June 30, 2019, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations (see Note 4, Leases, to our condensed consolidated financial statements).
We have provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. (“BNA”), an indirect wholly-owned subsidiary, which guarantees all amounts due and owing by BNA, to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.
In addition, Bunge Limited has provided full and unconditional parent level guarantees of the outstanding indebtedness under certain credit facilities entered into and senior notes issued by its 100% owned subsidiaries. At June 30, 2019, debt with a carrying amount of $5,890 million related to these guarantees is included in our condensed consolidated balance sheet. This debt includes the senior notes issued by two of our 100% owned finance subsidiaries, Bunge Limited Finance Corp. and Bunge Finance Europe B.V. There are largely no restrictions on the ability of Bunge Limited Finance Corp. and Bunge Finance Europe B.V. or any other of our subsidiaries to transfer funds to Bunge Limited.

Dividends
We paid a regular quarterly cash dividend of $0.50 per share on June 3, 2019 to common shareholders of record on May 20, 2019. In addition, we paid a quarterly dividend of $1.21875 per share on our cumulative convertible perpetual preference shares on June 1, 2019 to shareholders of record on May 15, 2019. On May 22, 2019, we announced that our Board

53

Table of Contents

of Directors had approved a regular quarterly cash dividend of $0.50 per common share. The dividend will be payable on September 3, 2019 to common shareholders of record on August 20, 2019. We also announced on May 22, 2019 that we will pay a quarterly cash dividend of $1.21875 per share on our cumulative convertible perpetual preference shares on September 1, 2019 to shareholders of record on August 15, 2019.

Critical Accounting Policies and Estimates
Critical accounting policies are defined as those policies that are significant to our financial condition and results of operations and require management to exercise significant judgment. For a complete discussion of our accounting policies, see Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the Securities and Exchange Commission on February 22, 2019. There were no material changes to Bunge’s critical accounting policies during the six months ended June 30, 2019. For recent accounting pronouncements refer to Note 2 to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

54

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Risk Management
As a result of our global activities, we are exposed to changes in, among other things, agricultural commodity prices, transportation costs, foreign currency exchange rates, interest rates and energy costs which may affect our results of operations and financial position. We actively monitor and manage these various market risks associated with our business activities. Our risk management decisions take place in various locations, but exposure limits are centrally set and monitored, operating under a global governance framework. Additionally, our Board of Directors' Finance and Risk Policy Committee oversees our global market risk governance framework, including risk management policies and limits.
We use derivative instruments for the purpose of managing the exposures associated with commodity prices, transportation costs, foreign currency exchange rates, interest rates and energy costs and for positioning our overall portfolio relative to expected market movements in accordance with established policies and procedures. We enter into derivative instruments primarily with commodity exchanges in the case of commodity futures and options, major financial institutions, or approved exchange clearing shipping companies in the case of ocean freight. While these derivative instruments are subject to fluctuations in value, for hedged exposures those fluctuations are generally offset by the changes in fair value of the underlying exposures. The derivative instruments that we use for hedging purposes are intended to reduce the volatility on our results of operations; however, they can occasionally result in earnings volatility, which may be material. See Note 12 to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q for a more detailed discussion of our use of derivative instruments.
Credit and Counterparty Risk
Through our normal business activities, we are subject to significant credit and counterparty risks that arise through normal commercial sales and purchases, including forward commitments to buy or sell, and through various other OTC derivative instruments that we utilize to manage risks inherent in our business activities. We define credit and counterparty risk as a potential financial loss due to the failure of a counterparty to honor its obligations. The exposure is measured based upon several factors, including unpaid accounts receivable from counterparties and unrealized gains from forward cash contracts, as well as OTC derivative instruments. Credit and counterparty risk also includes sovereign credit risk. We actively monitor credit and counterparty risk through regular review of exposures and credit analysis by regional credit teams, as well as review by global and corporate committees which monitor counterparty performance. We record provisions for counterparty losses from time to time as a result of our credit and counterparty analysis.
During periods of tight conditions in global credit markets, downturns in regional or global economic conditions, and/or significant price volatility, credit and counterparty risks are heightened. This increased risk is monitored through, among other things, exposure reporting, increased communication with key counterparties, management reviews and specific focus on counterparties or groups of counterparties that we may determine as high risk. In addition, we have limited exposures and limits in certain cases and reduced our use of non-exchange cleared derivative instruments.
Commodities Risk
We operate in many areas of the food industry, from agricultural raw materials to the production and sale of branded food products. As a result, we purchase and produce various materials, many of which are agricultural commodities, including: soybeans, soybean oil, soybean meal, palm oil, softseeds (including sunflower seed, rapeseed and canola) and related oil and meal derived from them, wheat, barley, shea nut, and corn. In addition, we grow and purchase sugarcane to produce sugar, ethanol and electricity. Agricultural commodities are subject to price fluctuations due to a number of unpredictable factors that may create price risk. As described above, we are also subject to the risk of counterparty non-performance under forward purchase or sale contracts. From time to time, we have experienced instances of counterparty non-performance, as a result of significant declines in counterparty profitability under these contracts due to significant movements in commodity prices between the time the contracts were executed and the contractual forward delivery period.
We enter into various derivative contracts with the primary objective of managing our exposure to adverse price movements in the agricultural commodities used and produced in our business operations. We have established policies that limit the amount of unhedged fixed price agricultural commodity positions permissible for our operating companies, which are generally a combination of volumetric and value-at-risk ("VaR") limits. We measure and review our net commodities position on a daily basis. We also employ stress testing techniques in order to quantify its exposures to price and liquidity risks under non-normal or event driven market conditions.
Our daily net agricultural commodity position consists of inventory, forward purchase and sale contracts, and OTC and exchange traded derivative instruments, including those used to hedge portions of our production requirements. The fair value of that position is a summation of the fair values calculated for each agricultural commodity by valuing all of our

55

Table of Contents

commodity positions at quoted market prices for the period where available or utilizing a close proxy. VaR is calculated on the net position and monitored at the 95% confidence interval. In addition, scenario analysis and stress testing are performed. For example, one measure of market risk is estimated as the potential loss in fair value resulting from a hypothetical 10% adverse change in prices. The results of this analysis, which may differ from actual results, are as follows:
 
 
Six Months Ended
June 30, 2019
 
Year Ended
December 31, 2018
(US$ in millions)
 
Value
 
Market
Risk
 
Value
 
Market
Risk
Highest daily aggregated position value
 
$
405

 
$
(41
)
 
$
2,131

 
$
(213
)
Lowest daily aggregated position value
 
$
(673
)
 
$
(67
)
 
$
(624
)
 
$
(62
)
Ocean Freight Risk
Ocean freight represents a significant portion of our operating costs. The market price for ocean freight varies depending on the supply and demand for ocean vessels, global economic conditions and other factors. We enter into time charter agreements for time on ocean freight vessels based on forecasted requirements for the purpose of transporting agricultural commodities. Our time charter agreements generally have terms ranging from two months to approximately seven years. We use financial derivatives, generally freight forward agreements, to hedge portions of our ocean freight costs. The ocean freight derivatives are included in other current assets and other current liabilities on the condensed consolidated balance sheets at fair value.
Energy Risk
We purchase various energy commodities such as electricity, natural gas and bunker fuel, that are used to operate our manufacturing facilities and ocean freight vessels. We produce ethanol as part of our sugar milling operations and we also refine and produce biofuels. The energy commodities are subject to price risk. We use financial derivatives, including exchange traded and OTC swaps and options for various purposes to manage our exposure to volatility in energy costs and market prices. These energy derivatives are included in other current assets and other current liabilities on the condensed consolidated balance sheets at fair value.
Currency Risk
Our global operations require active participation in foreign exchange markets. Our primary foreign currency exposures are the Brazilian real, Canadian dollar, the Euro and the Chinese yuan/renminbi. To reduce the risk arising from foreign exchange rate fluctuations, we enter into derivative instruments, such as foreign currency forward contracts, swaps and options. The changes in market value of such contracts have a high correlation to the price changes in the related currency exposures. The potential loss in fair value for such net currency position resulting from a hypothetical 10% adverse change in foreign currency exchange rates as of June 30, 2019 was not material.
When determining our exposure, we exclude intercompany loans that are deemed to be permanently invested. The repayments of permanently invested intercompany loans are not planned or anticipated in the foreseeable future and therefore, are treated as analogous to equity for accounting purposes. As a result, the foreign exchange gains and losses on these borrowings are excluded from the determination of net income and recorded as a component of accumulated other comprehensive income (loss) in the condensed consolidated balance sheets. Included in other comprehensive income (loss) are foreign exchange gains of $18 million for the six months ended June 30, 2019 and foreign exchange losses of $344 million for the year ended December 31, 2018 related to permanently invested intercompany loans.
We have significant operations in Argentina and, up until June 30, 2018, had utilized the official exchange rate of the Argentine peso published by the Argentine government for its commercial transactions and re-measurement purposes of financial statements. Argentina has experienced negative economic trends, as evidenced by multiple periods of increasing inflation rates, devaluation of the peso, and increasing borrowing rates, requiring the Argentine government to take mitigating actions. During the second quarter of 2018, it was determined that Argentina's economy should be considered highly inflationary, and as such, beginning on July 1, 2018, our Argentine subsidiaries changed their functional currency to the U.S. dollar. This change in functional currency did not have a material impact on our consolidated financial statements.
Interest Rate Risk
We have debt in fixed and floating rate instruments. We are exposed to market risk due to changes in interest rates. We may enter into interest rate swap agreements to manage our interest rate exposure related to our debt portfolio.

56

Table of Contents

The aggregate fair value of our short and long-term debt based on market yields at June 30, 2019, was $6,407 million with a carrying value of $6,348 million. There was no significant change in our interest rate risk at June 30, 2019.
A hypothetical 100 basis point increase in the interest yields on our senior note debt at June 30, 2019 would result in a decrease of approximately $65 million in the fair value of our debt. Similarly, a decrease of 100 basis points in the interest yields on our debt at June 30, 2019 would cause an increase of approximately $56 million in the fair value of our debt.
A hypothetical 1% change in LIBOR would result in a change of approximately $48 million in our interest expense on our variable rate debt at June 30, 2019. Some of our variable rate debt is denominated in currencies other than in U.S. dollars and is indexed to non-U.S. dollar-based interest rate indices, such as EURIBOR and TJLP and certain benchmark rates in local bank markets. As such, the hypothetical 1% change in interest rate ignores the potential impact of any currency movements.

ITEM 4.
CONTROLS AND PROCEDURES
Disclosure Controls and Procedures - Disclosure controls and procedures are the controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the principal executive and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
As of June 30, 2019, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as that term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.
Internal Control Over Financial Reporting - There have been no changes in the Company’s internal control over financial reporting during the second quarter ended June 30, 2019, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
As part of the GCP (see Note 3 -  Global Competitiveness Program, to our condensed consolidated financial statements), the Company is simplifying organizational structures, streamlining processes and consolidating back office functions globally. In connection with this initiative, the Company has and will continue to align and streamline the design and operation of its internal controls over financial reporting. This initiative is not in response to any identified deficiency or weakness in the Company’s internal controls over financial reporting, but is expected, over time, to result in changes to the Company's internal controls over financial reporting.


57

Table of Contents

PART II.
INFORMATION
ITEM 1.
LEGAL PROCEEDINGS
From time to time, we are involved in litigation and other claims, investigations and proceedings incidental to our business. While the outcome of these matters cannot be predicted with certainty, we believe the outcome of these proceedings, net of established reserves, will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.
For a discussion of certain legal and tax matters relating to Argentina and Brazil, see Note 16 to our condensed consolidated financial statements included as part of this Quarterly Report on Form 10-Q. Additionally, we are a party to a large number of labor and civil and other claims relating to our Brazilian operations. We have reserved an aggregate of $70 million and $65 million, for labor and civil claims, respectively, as of June 30, 2019. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments and supplementary retirement benefits. The civil claims relate to various legal proceedings and disputes, including disputes with suppliers and customers and include approximately 132 million Brazilian reais (approximately $35 million as of June 30, 2019) related to a legacy environmental claim in Brazil.

ITEM 1A.
RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2018 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.

ITEM 3.
DEFAULTS UPON SENIOR SECURITIES
None.

ITEM 4.
MINE SAFETY DISCLOSURES
Not applicable.

ITEM 5.
OTHER INFORMATION
None

ITEM 6.
EXHIBITS
(a) The exhibits in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.

58

Table of Contents

EXHIBIT INDEX
31.1*
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
 
 
 
31.2*
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
 
 
 
32.1*
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
 
 
 
32.2*
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
 
 
 
 
Employment Agreement, dated April 25, 2019, between Bunge Limited and Gregory A. Heckman (incorporated by reference from the Company’s Current Report on Form 8-K filed on April 26, 2019).
 
Employment Offer Letter, dated May 7, 2019, between Bunge Limited and John W. Neppl
 
 
 
101 SCH
 
XBRL Taxonomy Extension Schema Document
101 CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
101 LAB
 
XBRL Taxonomy Extension Labels Linkbase Document
101 PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
101 DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
101 INS
 
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
*
Filed herewith.
E-1

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
BUNGE LIMITED
 
 
 
 
 
 
Date: July 31, 2019
 
By:
/s/ John W. Neppl
 
 
 
John W. Neppl
 
 
 
Executive Vice President, Chief Financial Officer
 
 
 
 
 
 
 
 
 
 
 
/s/ J. Matt Simmons, Jr.
 
 
 
J. Matt Simmons, Jr.
 
 
 
Controller and Principal Accounting Officer

59



OFFERLTRNEPPL05719FIN_IMAGE1.JPG

Mr. John Neppl
[ADDRESS REDACTED]


May 7, 2019


Dear John,


1.
Offer and Position

We are very pleased to extend an offer of employment to you for the position of EVP, Chief Financial Officer of Bunge Limited (the “Company”). You will report directly to the Chief Executive Officer of Bunge. This offer of employment is subject to the terms and conditions set forth in this letter and are conditioned on your satisfactory completion of certain requirements, as more fully explained below. We are looking forward to having you on the team leading this very important area of the Company and helping to further Bunge's growth and profitability.

2.
Start Date

Subject to satisfaction of the conditions described in this letter, your start date will be May 29, 2019 (the “Start Date”)

3.
Duties

In your capacity as Chief Financial Officer, you will perform such duties and responsibilities that are commensurate with your position and such other duties as may be assigned to you from time to time by the Board of Directors of the Company (the “Board”) or the Chief Executive Officer of the Company, consistent with your role as a senior executive officer of the Company. You agree to devote your full business time, attention and best efforts to the performance of your duties and to the furtherance of the Company's interests. Notwithstanding the foregoing, you may perform charitable and community activities and, subject to the Board’s prior written approval, serve on the boards of other entities (public or private), provided, that none of these activities interferes with the performance of your duties under this letter or creates a conflict of interest.

4.
Location

Your principal place of employment will be at our corporate headquarters in White Plains, New York, subject to business travel as needed to fulfil your employment duties and responsibilities.


5.
Base Salary

In consideration of your services, you will be paid an initial base salary of $700,000 per annum, subject to annual review by the Board for possible increases, payable in accordance with the standard payroll practices of the Company.

6.
Joining Considerations

You will be paid a one-time signing bonus of $500,000 (gross) within 60 days following the Start Date. If your employment is terminated by the Company for Cause (as defined in section 12) or if you resign your employment within 24 months of the Start Date, you agree to repay a pro rata amount of the gross amount of the signing bonus based on the number of months worked during the first 24 months. For example, if termination occurs for Cause or if you resign after 12 months, you agree to repay 50% or $250,000 of the signing bonus amount.

As soon as practicable following the Start Date, you will also receive the following one-time equity awards:

a)
A one-time equity award of 9,000 performance based restricted stock units that will vest subject to the satisfaction of the Company based performance objectives set forth in the award agreement on March 14, 2022.

b)
A one-time equity award of 14,000 restricted time based stock units that will vest in equal thirds on June 1, 2020; June, 1 2021; and June 1, 2022.

These awards will be subject to the terms and conditions of the EIP and the applicable award agreement.

To the extent permitted by applicable law, you authorize the Company to deduct from any amount due to you, including your final paycheck and any severance benefits, the signing bonus amount subject to repayment. If such deductions are insufficient to reimburse the Company for the full amount owed, you will remain personally liable for the remaining balance.

7.
Annual Bonus Program

You will be eligible to participate in the Company's Annual Incentive Plan (or such successor plan) (the “AIP”). Your target bonus opportunity will be 100% of your base salary with a maximum bonus opportunity of 240% of target. Actual payments will be determined based on goals achieved against the applicable performance goals established by the Compensation Committee of the Board of Directors (the “Compensation Committee”), in its reasonable discretion for the performance period. Your annual bonus opportunity will be subject to the terms and conditions of the AIP (including timing of payments). For the 2019 calendar year, the value of your AIP award will be prorated per your start date with the Company.

8.
Long Term Incentive Program

You will be eligible for consideration for annual awards under the Company's 2016 Equity Incentive Program (or such successor plan) (“EIP”). The value of this award is established annually by the Compensation Committee based on a competitive analysis of Bunge's peer companies and other factors which impact the business. Awards are typically granted in the form of stock options and performance based restricted stock units during the first quarter of each year, as determined by the Compensation Committee. Your first grant will be valued at $2,000,000 and will be made in March 2020. All Long Term Incentive awards are subject to the terms and conditions of the EIP.

9.
Relocation

You will be eligible to participate in Bunge’s relocation program for your move to White Plains, New York. Bunge will cover temporary accommodation for the first 30 days post your start date, and provide you a broker to assist with home hunting services. Additional temporary commuting and living expenses to be based in White Plains prior to your permanent relocation will be at your personal expense.

10.
Benefits and Perquisites

You will be eligible to participate in the employee benefit plans and programs generally available to U.S. salaried employees, subject to the terms and conditions of such plans and programs. The Company will provide you with a description of the plans and programs separately. You will be entitled to paid time-off leave in accordance with the Company's policies in effect from time to time. In addition, you will be eligible for the following supplemental benefits for U.S. based Executive Committee members in accordance with the eligibility and other provisions of such plans and programs:

a)
The Bunge Supplemental Excess Contribution Plan under which you will be credited annually with an amount equal to the difference between (i) 8% of your salary earned plus your annual bonus (AIP) earned and (ii) the amount of company contributions credited to your accounts under the Savings (401-K) Plan and the Bunge Excess Contribution Plan.
b)
Perquisite Allowance: A flexible allowance of $9,600 per annum payable in 24 installments per year.

The Company reserves the right to amend, modify or terminate any of its benefit plans or programs at any time and for any reason. In addition, the Company will provide you with coverage under the Company’s customary director and officer indemnification arrangements, subject to applicable law.

11.
Severance

In the event your employment is involuntarily terminated by the Company without ''Cause" (as defined below) or you terminate your employment for Good Reason (as defined below), you will receive a lump sum payment equivalent to 12 months of your then prevailing base salary plus your target annual bonus (AIP).

Payment will be made within sixty (60) days following the date of your termination of employment.
You will also receive a prorated portion of the AIP for the calendar year in which you terminate employment based on a) the company and individual performance goals achieved for the applicable performance period, and b) a fraction where the numerator is the number of days in the fiscal year through your termination date and the denominator is the total number of days in the fiscal year, payable at the time that bonuses are payable to AIP participants generally.

These payments will be subject to the timely execution and non-revocation of a release of any employment related claims and covenants in form and substance reasonably satisfactory to both you and Bunge.

Equity treatment in the event of severance is outlined by the terms of the EIP.

12.
Separation Resulting From A Change of Control

Unless specifically prohibited by the EIP, in the event of (i) the occurrence of a Change of Control (as defined in the EIP) and (ii) a termination of your employment by the Company without Cause or by you for Good Reason as defined in Section 12 on or before the two year anniversary of the occurrence of a Change of Control (the “Change of Control Treatment”), the following treatment shall apply – and supersedes Section 11 above:

(a)
You will receive a lump sum payment equivalent to 24 months of your then prevailing base salary plus two times your target annual bonus (AIP).

(b)
Any restrictions imposed on outstanding RSUs (as defined in the EIP), if any, will be deemed to have expired;

(c)With respect to all outstanding Performance Units (as defined in the EIP) and other performance-based awards, the Compensation Committee (i) shall determine the greater of (x) the payout at the target number of Performance Units granted for the entire Performance Period (as defined in the EIP) and (y) the payout based upon the actual performance level attained as of the last day of the calendar quarter immediately prior to the date of your termination without Cause or resignation for Good Reason, in either case, after giving effect to the accumulation of Dividend Equivalents (as defined in the EIP), and (ii) shall pay to you the greater of such amounts, prorated based upon the number of complete and partial calendar months within the Performance Period which have elapsed as of the date of your termination without Cause or resignation for Good Reason (as applicable). Payment shall be made in cash or in shares, as determined by the Compensation Committee, in its discretion, on the 60th calendar day following the date of your termination of employment with the Company;

(d)All outstanding and unvested Options and SARs (as such terms are defined in the EIP) shall become immediately exercisable; and

(e)Any restrictions imposed on any outstanding and unvested Other Awards (as defined in the EIP) shall be deemed to have expired.

In the event of a Change of Control, any or all outstanding Awards (as defined in the EIP) may be assumed or replaced by the successor entity. In the alternative, the successor entity may substitute equivalent Awards that include the Change of Control Treatment or provide substantially similar consideration to you as was provided to shareholders of the Company (after taking into account the existing provisions of the Awards), which substantially similar
consideration shall include the Change of Control Treatment. In the event such successor entity refuses to assume, replace or substitute Awards, on the terms provided above, pursuant to a Change of Control, then notwithstanding any other provision in the EIP to the contrary, such Awards shall have their vesting accelerate as to all shares subject to such Awards immediately prior to the Change of Control and then such Awards will terminate. In addition, in the event such successor entity refuses to assume, replace or substitute Awards, on the terms above, the Compensation Committee will notify you in writing that such Awards will be exercisable for a reasonable period of time determined by the Compensation Committee in its discretion, and such Awards will terminate upon the expiration of such period. Awards need not be treated similarly in a Change of Control.

For purposes of this Agreement, “Cause” shall mean termination of your employment because of:
(a)    any willful act or omission or any act of gross negligence that constitutes a material breach by you of this Agreement;

(b)    the willful and continued failure or refusal of you to substantially perform the duties required of you as an employee of the Company;

(c)    your conviction of, or a plea of nolo contendere to, a felony, under U.S. law or applicable state law or similar offense under non-U.S. law, or any misdemeanor or similar offense under non-U.S. law involving moral turpitude (other than any traffic- related offense);

(d)    any willful commission of an act of fraud, forgery, theft, misappropriation or embezzlement; or

(e)    any other willful misconduct by you that is materially injurious to the financial condition, business or reputation of, or is otherwise materially injurious to, any member of the Bunge Group;

provided, however, that, if any such Cause relates to subsections (a) or (b) of this Section 12, the Company may not terminate your employment for Cause unless (i) the Company first gives you notice of its intention to terminate and of the grounds for such termination within 90 days following such event and (ii) you have not, within 30 days following receipt of such notice, cured such Cause in a manner that is reasonably satisfactory to the Compensation Committee, or in the event such Cause is not susceptible to cure within such 30-day period, the Compensation Committee reasonably determines that you have not taken all reasonable steps within such 30- day period to cure such Cause as promptly as practicable thereafter.

For purposes of this Agreement, “Good Reason” shall mean any of the following:
(a)a failure by the Company to pay material compensation due and payable to you in connection with your employment;

(b)a material diminution of your authority, responsibilities or positions set forth in Section 3; or

(c)any relocation at the request of the Company to a location more than 50 miles of your principal place of employment;

provided, however, that no event or condition described in this Section 12 shall constitute Good Reason unless (i) you gives the Company written notice of your objection to such event or condition within 90 days following the occurrence of such event or condition, (ii) such event or condition is not corrected, in all material respects, by the Company in a manner that is reasonably satisfactory to you within 30 days following the Company’s receipt of such notice (or in the event that such event or condition is not susceptible to correction within such 30-day period, you reasonably determine that the Company has not taken all reasonable steps within such 30-day period to correct such event or condition as promptly as practicable thereafter) and (iii) you resign from employment with the Company not more than 30 days following the expiration of the 30-day period described in the foregoing clause (ii).

13.
Restrictive Covenants.
As a condition of your employment and the benefits set forth in this letter, you agree and acknowledge that you will be subject to the restricted covenants set forth in the EIP award agreement applicable to your equity awards.

14.
Withholding

Any amounts paid to you as an employee of the Company will be subject to all applicable withholdings and deductions.

15.
Share Ownership Requirements

You will be required to comply with the Company's share ownership requirements as in effect from time to time. The existing share ownership guidelines are set forth in Attachment A.

16.
At-will Employment

Your employment with the Company will be at-will, meaning that you or the Company may terminate the employment relationship at any time, with or without cause, and with or without notice and for any reason or no particular reason. Although your compensation and benefits may change from time to time, the at-will nature of your employment may only be changed by an express written agreement signed by an authorized officer of the Company.

17.
Section 409A

All payments under this offer will be subject to all applicable tax withholdings and payroll deductions. This offer letter is intended to comply with Section 409A of the Internal Revenue Code (“Section 409A”) or an exemption thereunder and shall be construed and administered in accordance with Section 409A or an applicable exemption. Any payments under this letter that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided under this letter shall be treated as a separate payment. Any payments to be made under this letter upon a termination of employment shall only be made upon a "separation from service" under Section 409A. If payment of any amount subject to Section 409A is triggered by a separation from service that occurs while you are a “specified employee” (as defined by Section 409A) with, and if such amount is scheduled to be paid within six (6) months after such separation from service, the amount shall accrue without interest and shall be paid the first business day after the end of such six-month period, or, if earlier, within 15 days after the appointment of the personal representative or executor of your estate following the Employee’s death. If any payment subject to Section 409A is contingent on the delivery of a release by you and could occur in either of two years, the payment will occur in the later year.

18.
Clawback

Any amounts payable under this letter will be subject to any statute and/or regulation and any policy (whether currently in existence or later adopted) established by the Company that provides for the clawback or recovery of compensation.

19.
Amendment.

This letter may only be amended or modified by a written agreement executed by the parties to this letter or their respective successors or legal representatives.

20.
Governing Law

This letter shall be subject to the laws of the state of New York, without regard to conflict of law principles. The parties to this letter agree that any litigation or other proceeding commenced by either party shall be commenced in the federal or state courts of New York.

21.
Entire Agreement.

This letter and the referenced documents and agreements constitute the entire agreement between you and the Company with respect to the subject matter hereof and supersede any and all prior or contemporaneous oral or written representations, understandings, agreements or communications between you and the Company concerning those subject matters.

22.
Contingent Offer

This offer is contingent upon:

(a)Verification of your right to work in the United States, as demonstrated by your completion of an I-9 form upon hire and your submission of acceptable documentation (as noted on the I-9 form) verifying your identity and work authorization within three days of your Start Date.

(b)
Satisfactory completion of reference checks and a background investigation.

(c)
Successful completion of a drug screen.

This offer will be withdrawn if any of the above conditions are not satisfied.


23.
Representations

By accepting this offer, you represent that you are able to accept this job and carry out the work that it would involve without breaching any legal restrictions on your activities, such as non- competition, non-solicitation or other work-related restrictions imposed by a current or former employer. You also represent that you will inform the Company about any such restrictions and provide the Company with all relevant information, including any agreements between you and your current or former employer describing such restrictions on your activities. You further confirm that you will not remove or take any documents or proprietary data or materials of any kind, electronic or otherwise, with you from your current or former employer to the Company without written authorization from your current or former employer, nor will you use or disclose any such confidential information during the course and scope of your employment with the Company.


John, I am delighted that you will be assuming the role of Chief Financial Officer for Bunge. If this letter expresses your understanding of our agreement, your signature below will indicate your acceptance of the terms herein. Should you have any questions do not hesitate to call me.


Sincerely,






Deborah Borg

Chief Human Resources and Communications Officer Bunge Limited



Acceptance of Offer

I have read, understood and accept all the terms of the offer of employment as set forth in the foregoing letter. I have not relied on any agreements or representations, express or implied, that are not set forth expressly in the foregoing letter and this letter supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to the subject matter of this letter.
John Neppl


Signed .....................................................



Date ........................................................

[ATTACHMENT A]

BUNGE LIMITED
SHARE OWNERSHIP GUIDELINES

To better align the personal interest of senior management with the interests of Bunge's shareholders, the Board has established share ownership guidelines. The guidelines detail the minimum amount of Bunge common shares senior executives should hold. The guidelines took effect in 2005, and are required to be met within five years* of their effective date or, if later, from when the individual initially joins the Executive Committee.

The guidelines are based on a multiple of the executive's base salary. For Bunge's Chief Executive Officer, the guideline is six times base salary. For executives reporting directly to the Chief Executive Officer, the guideline is three times base salary.

Shares deemed to be owned for purposes of the share ownership guidelines include shares owned directly by the executive, hypothetical share units held under Bunge’s deferred compensation plans, 50 percent of the value of unvested time based restricted stock units and 50 percent of the difference between the exercise price and the fair market value of Bunge’s common shares for vested, in-the-money stock options. Unvested stock options and unearned performance-based restricted stock units do not count towards achievement of the guidelines. Senior executives are required to hold 50 percent of the net shares they acquire through Bunge's long-term incentive plans (such as stock options or restricted stock units) until the guideline is met, 100 percent if the guideline has net been met following the expiration of the five-year accumulation period*

*Measured as of April 30th following the fifth anniversary of the date of appointment. Acknowledged



Date:     




EXHIBIT 31.1
Certification of Chief Executive Officer
Pursuant to Section 302 of the Sarbanes Oxley Act of 2002
 
I, Gregory A. Heckman, certify that:
1.
I have reviewed this report on Form 10-Q of Bunge Limited (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
July 31, 2019
/s/ Gregory A. Heckman
 
Gregory A. Heckman
 
Chief Executive Officer (Principal Executive Officer)
 





EXHIBIT 31.2
Certification of Chief Financial Officer
Pursuant to Section 302 of the Sarbanes Oxley Act of 2002
 
I, John W. Neppl, certify that:
1.
I have reviewed this report on Form 10-Q of Bunge Limited (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
July 31, 2019
/s/ John W. Neppl
 
John W. Neppl
 
Executive Vice President, Chief Financial Officer
 





EXHIBIT 32.1
Certification by the Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes Oxley Act Of 2002
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, the undersigned officer of Bunge Limited, a Bermuda limited liability company (the “Company”), does hereby certify that, to the best of such officer’s knowledge:
(1)
The accompanying Report of the Company on Form 10-Q for the quarter ended June 30, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 31, 2019
 
/s/ Gregory A. Heckman
 
Gregory A. Heckman
 
Chief Executive Officer (Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to Bunge Limited and will be retained by Bunge Limited and furnished to the Securities and Exchange Commission or its staff upon request.





EXHIBIT 32.2
Certification by the Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes Oxley Act Of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, the undersigned officer of Bunge Limited, a Bermuda limited liability company (the “Company”), does hereby certify that, to the best of such officer’s knowledge:
(1)
The accompanying Report of the Company on Form 10-Q for the quarter ended June 30, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 31, 2019
 
/s/ John W. Neppl
 
John W. Neppl
 
Executive Vice President, Chief Financial Officer
A signed original of this written statement required by Section 906 has been provided to Bunge Limited and will be retained by Bunge Limited and furnished to the Securities and Exchange Commission or its staff upon request.